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Alcohol dependence (alcoholism) is a complex disease influenced by both 
environmental factors and genetic predisposition.  Mouse models have been used to study 
many alcohol dependence-related traits and the genetics that underlie them.  Two of the 
most commonly used mice in alcohol research are the C57BL/6J (B6) and DBA/2J (D2) 
inbred strains, which diverge on several alcohol-related traits including the development 
of acute physical dependence.  Here we utilized the B6 and D2 mice as a genetic model 
of acute physical dependence, coupled with mRNA Differential Display (DD) and cDNA 
microarray analysis, to uncover the transcriptional response of the brain to an acute dose 
of alcohol as a function of time.  About 150 genetically divergent and alcohol-responsive 
genes were identified between the whole brains of B6 and D2 mice using DD and were 
added as additional targets to the mouse microarrays.  Microarray analysis of the 
prefrontal cortex of B6 and D2 mice revealed strain-specific, acute alcohol-responsive 
transcriptome remodeling manifested as temporal patterns of gene expression.  Distinct 
expression patterns were identified for physiologically relevant alcohol-related 
 vii
consequences including intoxication, withdrawal and neuroadaptation.  In silico 
characterization of the differentially expressed genes showed genotype dependent and 
independent transcriptional regulation and functional classification.  In addition, 
categorization of differentially expressed genes by their cellular profiles revealed that 
some of the genes were known to be more highly expressed in either excitatory or 
inhibitory neuronal cell types.  Our results indicate that the B6 and D2 prefrontal cortices 
have very different cellular and molecular responses to acute alcohol exposure.  The 
specific roles that the genes identified in this study may play in mediating the divergent 
alcohol-related behavior between the strains warrant further study. 
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Rationale 
Alcohol dependence (alcoholism) is a complex disease influenced by both 
environmental factors and genetic predisposition.  The genes contributing to the risk for 
developing alcohol dependence are numerous and of small individual effect.  Several 
behavioral, pharmacological and molecular methodologies have been used over the years 
to identify genes contributing to every aspect of this disease.  The current hypothesis is 
that alcohol disrupts the normal homeostasis of neurons in the brain, affecting neuronal 
communication and ultimately neuronal circuits between brain regions.  Over time, the 
brain adapts to the presence of alcohol such that it becomes physically dependent on the 
alcohol and functions poorly without it.  Gene expression is thought to play an important 
role in this brain neuroadaptation.  Although progress has been made in identifying 
individual genes associated with alcohol dependence, to truly understand the molecular 
basis of a disease as complex as alcohol dependence, studies must go beyond that of 
individual genes.  This study combines a genetically divergent mouse model of physical 
dependence, mRNA Differential Display, cDNA microarrays and a time course following 
alcohol administration to simultaneously identify thousands of genes that are 
differentially expressed as a result of genetic predisposition, alcohol and time.  Genes that 
are differentially expressed can be classified according to their function, common 
transcription factor binding sites or cellular identities and specific, testable hypotheses 
can be developed about how genes or gene families contribute to the development of 
alcohol dependence. 
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Hypotheses 
Alcohol-related and genetically divergent, alcohol-related gene expression changes occur 
in C57BL/6J and DBA/2J mouse brain as a result of acute alcohol exposure. 
 
Gene expression differences exist between the brains of C57BL/6J and DBA/2J mice. 
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CHAPTER 1:  INTRODUCTION 
Alcohol dependence 
Alcohol dependence is a faceless disease.  It does not care about nationality, race, 
gender or age.  The moment someone takes his or her first drink of alcohol, the 
possibility exists that he or she may become dependent on alcohol.  Risk for developing 
the disease is influenced by genetics and the environment (Aston and Hill, 1990; Crabbe 
and Goldman, 1992).  There is no cure for alcohol dependence and although treatment 
options exist, they are often population- or person-specific in their effectiveness. 
In the 1980s, the American Psychiatric Association (APA) divided the term 
“alcoholism” into two categories—“alcohol abuse” and “alcohol dependence” (APA, 
1980).  The Diagnostic and Statistical Manual of Mental Disorders-IV-TR (APA, 2000) 
defines these terms as follows: 
(1) Alcohol abuse:  “A maladaptive pattern of drinking, leading to 
clinically significant impairment or distress as manifested by at least 
one of the following in a 12-month period:  failure to fulfill major 
role obligations at work, school or home, recurrent alcohol-related 
legal, social or interpersonal problems or recurrent participation in 
physically hazardous situations.” 
(2) Alcohol dependence:  “A maladaptive pattern of drinking, leading to 
clinically significant impairment or distress as manifested by 3 or 
more of the following in a 12-month period:  tolerance, withdrawal, 
impaired control, a great deal of time spent in alcohol-related 
activities or continued use despite negative consequences.” 
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As the names imply, dependence is the key difference between the two categories.  
Chronic alcohol abuse causes a “re-wiring” of the brain, creating a state of dependence 
where the body functions poorly without the presence of alcohol. 
PREVALENCE 
The prevalence of alcohol dependence and abuse places a tremendous social and 
economic strain on the United States each year.  Roughly 4-14% of the U.S. population 
meet the criteria for alcohol abuse or dependence (Regier et al., 1990; Grant et al., 1994; 
Grant et al., 2004).  According to the most recent National Survey on Drug Use and 
Health performed by the Substance Abuse and Mental Services Administration 
(SAMHSA), the percentage of current alcohol drinkers in the U.S. (ages 12 and older) is 
50% (SAMHSA, 2004). 
Alcohol consumption has been linked to the development chronic diseases such as 
cancer, diabetes, cardiovascular disease, cirrhosis of the liver, depression and epilepsy.  
The more alcohol consumed on a daily basis, the greater the risk for disease development.  
In addition, alcohol consumption contributes to acute injuries, such as automobile 
accidents.  Even moderate doses of alcohol have effects on reaction time, coordination 
and cognitive processing (Rehm et al., 2003).  Alcohol use also increases the risk of 
injury from automobile and bicycle accidents, falls, fires, sports activities and fights by 
increasing their prevalence and preventing the body from recovering as quickly after 
incurring damage.   
It is not surprising that the economic impact of alcohol abuse and dependence in 
the U.S. is substantial.  The estimated cost of alcohol abuse in 1998 was $185 billion 
(Harwood, 1998).  By applying the same formula used to generate this estimate, the cost 
in 2006 would be $249 billion.  That estimate equates to $833 per person, based on the 
U.S. population in July 2006 (http://www.cia.gov).  Therefore, each U.S. citizen is 
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contributing over $800 per year to the cost of alcohol abuse treatment, prevention, 
research and training, medical consequences of alcohol consumption, lost productivity at 
work, crime and property damage (Harwood, 1998).  Obviously this is an overwhelming 
burden to society that calls for a better understanding of the biology of the disease so that 
more effective prevention and treatment options are available. 
TREATMENT 
Treatment options for alcohol abuse and dependence fall into two broad 
categories:  non-pharmacotherapy and pharmacotherapy.  Non-pharmacotherapy includes 
a wide range of behavior modification techniques and programs, including Cognitive-
Behavioral Therapy, Motivational Enhancement Therapy, Couples Therapy, Brief 
Interventions and 12-step self-help programs such as Alcoholics Anonymous (AA) 
(Fuller and Hiller-Sturmhofel, 1999; Steinglass, 1999). 
Only three medications are currently approved by the U.S. Food and Drug 
Administration (FDA) for treating alcohol dependence.  They are disulfiram, naltrexone 
and acamprosate.  Disulfiram is an aldehyde dehydrogenase blocker, which causes an 
increase in acetaldehyde concentrations in the body, resulting in unpleasant side effects 
(Heilig and Egli, 2006).  Naltrexone and acamprosate both act on receptor systems in the 
brain.  Naltrexone is an opiate antagonist that blocks the rewarding effects of alcohol and 
acamprosate is a glutamate antagonist thought to decrease the effects of the excitatory 
neurotransmitter glutamate, thereby increasing abstinence (Volpicelli et al., 1992; Swift, 
1995; Dahchour and De Witte, 2000; Littleton and Zieglgansberger, 2003; Heilig and 
Egli, 2006).  A number of other drugs are currently being tested to treat dependence.  
These include baclofen, which activates GABAB receptors and reduces alcohol craving 
and consumption (Addolorato et al., 2002), topiramate, which reduces craving by acting 
on AMPA-kainate receptors to decrease glutamate activity while increasing GABA 
 6
activity (Johnson et al., 2003) and ondansetron, which reduces the activity of the 
serotonin (5-HT3) receptor and reduces the desire to drink (Johnson et al., 2000).  In 
addition, a recent study has tested the Chinese herbal root, kudzu, for its effectiveness in 
reducing alcohol intake in humans (Lukas et al., 2005).  The study found that participants 
drank less beer in a single sitting after being treated with kudzu extract for seven days. 
Despite the wide mechanistic range of current medications to treat dependence, 
none are universally effective.  This disparity is likely the result of genetic makeup.  The 
effectiveness of the drug ondansetron is a perfect example of how a drug can selectively 
work on a subset of people.  Ondansetron is more effective in early-onset alcoholics 
(alcohol-dependent before age 25) than late-onset alcoholics (alcohol-dependent after age 
25) (Johnson et al., 2000).  The hypothesis currently being tested is that this observation 
may be the result of a polymorphism in the promoter region of the 5-HT3 receptor gene 
between these two types of alcoholics.  Therefore, treatments may need to be tailored to 
individuals or subsets of alcoholics to be most effective.  It is crucial to identify both 
“predisposition” genes as well as genes affected by alcohol, so that clinicians may be able 
to identify individuals at risk for developing the disease and treat them with the most 
appropriate drug. 
PHYSIOLOGY 
Alcohol Metabolism 
Alcohol is metabolized in a two-step process in the liver.  Alcohol dehydrogenase 
(ADH) converts alcohol to acetaldehyde, which is then converted to acetate by aldehyde 
dehydrogenase (ALDH).  Acetate subsequently enters the Krebs cycle to become carbon 
dioxide and water.  Depending on the quantity consumed and the rate of consumption, a 
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small portion of the alcohol that is imbibed does not get metabolized in the liver and is 
instead excreted through the breath and urine (Wallgren, 1970).   
The metabolism of alcohol in the body can be described as zero order metabolism, 
meaning the rate of metabolism does not change with quantity consumed.  It takes 2-3 
hours for a male’s blood alcohol concentration (BAC) to return to zero after one standard 
drink (12 ounces of beer, 5 ounces of wine, or 1.5 ounces of 80 proof distilled spirits) on 
an empty stomach.  It takes seven hours after four standard drinks.  As a consequence of 
this slow rate of metabolism, alcohol can accumulate in the body, affecting organ systems 
and producing a state of intoxication (Wilkinson et al., 1977). 
Alcohol metabolism is affected by genetic makeup.  A polymorphism in the 
ALDH gene (called ALDH2*2) causes the enzyme to degrade acetaldehyde at a slower 
rate than normal.  Since acetaldehyde is mildly toxic, many unpleasant side effects, such 
as an increased pulse, dizziness, headaches and nausea can occur when alcohol is 
consumed by someone with this mutant allele.  Consequently, this allele appears to have 
a protective effect against the development of alcohol dependence (Kwon and Goate, 
2000). 
Chronic exposure 
Chronic alcohol abuse affects almost every organ in the body.  In addition to the 
myriad effects alcohol has on the brain, it can also have serious effects on the liver, the 
immune, cardiovascular and skeletal systems.  More people die in the U.S. from liver 
disease caused by long term, heavy alcohol use than any other form of liver disease 
(DeBakey et al., 1996).  Alcohol can decrease immune system efficiency, making abusers 
more susceptible to infection from bacterial pneumonia, pulmonary tuberculosis and 
hepatitis C (Cook, 1998).  Cardiovascular illnesses such as cardiomyopathy, coronary 
heart disease, high blood pressure, arrhythmia and stroke can all be the result of chronic 
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heavy drinking (Lucas et al., 2005).  Heavy drinking can also decrease bone mass and 
lead to osteoporosis (Chakkalakal, 2005). 
Even though long term alcohol abuse can have severe consequences on the body 
as a whole, alcohol dependence is a disease of the brain.  At the cellular level, alcohol is 
thought to alter brain gene expression and protein production as well as alter the structure 
of pre- and post-synaptic cells.  When these changes become permanent, they are referred 
to as a “neuroadaptation” of the brain to the presence of alcohol.  Neuropathological 
changes are also evident after chronic abuse.  Magnetic Resonance Imaging (MRI) 
studies of human subjects who drank heavily for 1-2 decades show loss of cortical gray 
and white matter (Pfefferbaum et al., 1992) and a reduction in brain volume (Agartz et 
al., 1999).  Post-mortem studies of human brain tissue from chronic alcoholics confirm 
this finding, revealing neuronal loss in the frontal cortex (Kril et al., 1997). 
Chronic alcoholics often suffer from vitamin deficiency, especially of thiamine 
(vitamin B1).  Up to 80% of alcoholics have this deficiency (Morgan, 1982) and many 
develop Wernicke-Korsakoff syndrome (WKS) as a result (Martin et al., 2003).  The 
symptoms of this syndrome include mental confusion, muscle incoordination and 
problems with learning and memory (Victor et al., 1989).  Brain damage can also occur 
indirectly as a result of liver damage.  For example, cirrhosis of the liver can cause the 
liver to function improperly, which leads to a condition known as hepatic 
encephalopathy.  Some of the symptoms of this disorder include anxiety, depression, 
cognitive deficits, personality changes and incoordination (Butterworth, 2003).      
Acute exposure 
Binge drinking is defined as drinking five or more drinks on the same occasion, 
within a couple hours of each other (SAMHSA, 2004).  Almost 23% of Americans aged 
12 or older reported having had at least one binge drinking episode in the 30 days prior to 
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the 2004 SAMHSA survey.  College age students (18-25 years old) report a higher 
frequency of binge drinking than any other age group (SAMHSA, 2004). 
Although some of the immediate effects of high alcohol consumption may be 
desirable, such as its anxiolytic and sedative effects, drinking excessive amounts of 
alcohol in a short period of time can cause severe consequences.  For example, acute 
alcohol intoxication can result in loss of balance and motor coordination, cognitive 
dysfunction, memory impairments, vomiting (with possible suffocation if person is 
unconscious) and blackouts (White, 2003). 
A number of studies have been done in rats that support both the behavioral and 
cellular impairments seen in humans after acute intoxication.  High doses of alcohol 
administered intragastrically to adult rats for 4-10 successive days caused 
neurodegeneration in the olfactory bulbs, piriform cortex, perirhinal cortex, entorhinal 
cortex and dentate gyrus (Collins et al., 1998; Obernier et al., 2002b).  The 
neurodegeneration occurring in these areas was attributed to necrotic cell death, as 
opposed to apoptosis (Obernier et al., 2002a).  Furthermore, as exposure increased over 
time, an increase in the number of regions affected was observed.  Additionally, Obernier 
et al. discovered that after the alcohol-treated animals experienced withdrawal, they 
performed more poorly on the reversal learning task than the control animals (Obernier et 
al., 2002b).  The authors propose that this behavior could be a result of cognitive 
dysfunction caused by the binge alcohol paradigm.  Therefore, long term alcohol abuse is 
not necessary to produce physical damage to the brain, and consequently, cognitive 
impairment. 
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Neurobiology of alcohol dependence 
BEHAVIORAL AND PHYSICAL MANIFESTATIONS 
The key to becoming dependent on alcohol is believed to involve neuroadaptation 
of the brain to the presence of alcohol.  Neuroadaptation most commonly occurs after 
repeated exposure to alcohol over many years (Nestler and Aghajanian, 1997), but it is 
possible to become dependent on alcohol after just a single exposure (Friedman, 1980; 
Kosobud and Crabbe, 1986; McCaul et al., 1990; Newlin and Pretorius, 1990; Crabbe et 
al., 1991)  Stable changes in brain chemistry (neuroadaptation) can be manifested as 
behaviors associated with alcohol abuse and dependence.  These complex behaviors 
include reward, craving, sensitization, tolerance and physical dependence (withdrawal) 
(Nestler and Aghajanian, 1997). 
The high that is often felt after consuming alcohol contributes to the compulsion 
to drink again.  Alcohol has positive reinforcing properties that act on the brain’s natural 
“reward” pathway (Figure 1.1).  This pathway is normally stimulated by natural rewards 
such as food and sex, but most drugs of abuse, including alcohol, stimulate it as well 
(Kelley and Berridge, 2002).  This pathway, called the mesocorticolimbic dopamine 
(DA) system, is comprised of DA neurons in the ventral tegmental area (VTA) projecting 
mainly to the nucleus accumbens (Nacc), amygdala and prefrontal cortex (PFC) (Kelley 
and Berridge, 2002).  A mechanism known to be involved in motivation and learning has 
been hypothesized to also contribute to the rewarding and reinforcing effects of alcohol.  
Co-activation of DA D1 receptors and glutamate N-methyl-D-aspartate (NMDA) 
receptors in the Nacc and PFC causes transcriptional consequences proven necessary for 
reward learning (Kelley and Berridge, 2002).  Since alcohol targets NMDA receptors and 
stimulates DA release, it is likely that these same pathways are at least partly responsible 
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for alcohol’s rewarding effects.  In addition, the constant stimulation of the reward 
pathway seen with chronic alcohol abuse can cause DA hypofunction.  Therefore one 
must consume more alcohol to make up for the decrease in DA release, thereby 
promoting reward and reinforcement (Weiss and Porrino, 2002).  Reward in animal 
models of alcohol dependence is often measured using two-bottle choice or lever press or 
by performing conditioned place preference.  A correlation has been shown between the 
level to which the animal self-administers or seeks out the environmental cues associated 
with receiving alcohol and the perceived reward (Crabbe et al., 1994).  The greater the 
reward, the more likely the animal (or human) will drink again.  Repeated alcohol 
exposure promotes brain neuroadaptation and eventually dependence. 
Figure 1.1:  Reward pathway for alcohol in human brain.  The mesocorticolimbic 
dopamine (DA) system is comprised of DA neurons in the ventral tegmental area (VTA) 
projecting mainly to the nucleus accumbens (Nacc), amygdala and prefrontal cortex 
(PFC). 
 
 
(Neuroscience, 2005) 
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A number of drugs of abuse produce a stimulant response upon exposure (Wise 
and Bozarth, 1987).  Cocaine, amphetamine and morphine are most commonly associated 
with this response, however, alcohol can cause this effect as well (Phillips et al., 1997).  
The stimulant response is augmented upon repeated exposure to the drug, a process 
termed behavioral sensitization (Phillips et al., 1997).  One way to assess behavioral 
sensitization in mice is by measuring locomotor response.  It has been hypothesized that 
behavioral sensitization accompanies euphoria and reward of the drug, possibly leading 
to uncontrolled drinking and the development of alcohol abuse and dependence.  Brain 
neuroadaptation may also be occurring during sensitization and may be a contributing 
factor to the feelings of euphoria and reward (Hunt and Lands, 1992; Schmidt et al., 
2000).  Evidence for neuroadaptation comes from studies where the sensitization 
phenotype has persisted for 3 months to 1 year, depending on the drug of abuse (Lessov 
and Phillips, 1998), suggesting that stable changes in brain chemistry may be occurring to 
maintain the phenotype. 
While sensitization refers to an increase in response to alcohol after repeated 
exposure, tolerance refers to a decrease in response.  Tolerance is defined as the reduction 
in response to alcohol after repeated exposure or the need for increased amounts of 
alcohol to achieve the same effects as when it was first introduced (Littleton et al., 1980; 
Le et al., 1992).  Basically, a higher dose of the drug is required to produce the same 
behavioral effects.  A rapid form of tolerance, known as acute (functional) tolerance, 
develops quickly (within minutes) (Palmer et al., 1985) after a single exposure to alcohol 
(Mellanby, 1919; LeBlanc et al., 1975; Erwin and McClearn, 1981; Erwin and Deitrich, 
1996).  Tolerance can be assessed using any behavioral, physiological or biochemical 
process that is affected by alcohol.  Examples in rodents include loss of righting reflex, 
motor incoordination, balance and hypothermia (Le et al., 1992).  The development of a 
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functional tolerance to the behavioral effects of alcohol implies that at least some 
neuroadaptation is occurring, suggesting that tolerance may be a prerequisite to a 
physically dependent state (Grieve and Littleton, 1979). 
Alcohol withdrawal is a clinical syndrome that can affect people who regularly 
consume alcohol and who decrease or stop their alcohol consumption suddenly (Saitz, 
1998).  Both acute and chronic alcohol use causes neural cells, circuits and systems to 
adapt to the presence of alcohol, such that when it is removed, withdrawal symptoms 
occur (Hyman and Malenka, 2001).  For example, long term alcohol abuse leads to an up-
regulation of glutamate receptors and a down-regulation of GABA receptors.  Upon 
cessation of alcohol’s presence, more glutamate can bind to the abundance of glutamate 
receptors and less GABA can bind to the decreased number of GABA receptors.  The 
consequence of this is over-excitation in the brain, which is what causes withdrawal 
seizures (Oscar-Berman and Marinkovic, 2003).  The severity of the withdrawal 
syndrome in rodents can be assessed using the Handling Induced Convulsion (HIC) 
scoring system (Goldstein and Pal, 1971; Goldstein, 1972; Crabbe et al., 1991; Terdal 
and Crabbe, 1994).  Two of the more common methods for eliciting withdrawal 
symptoms in mice are exposing them to alcohol vapor for three days (Goldstein and Pal, 
1971; Goldstein, 1972; Terdal and Crabbe, 1994) and injecting them with a single, high 
dose of alcohol (Crabbe et al., 1991; Metten and Crabbe, 1994). 
In conclusion, the factors that contribute to becoming dependent on alcohol are 
part of a vicious cycle.  As soon as alcohol is imbibed and its rewarding effects are felt, a 
concomitant change in brain chemistry and desire to continue drinking occur.  If this 
pattern continues over a long period of time, tolerance can develop and more alcohol will 
be necessary to maintain the same euphoric effect.  The body eventually becomes 
physically dependent on the alcohol and therefore if consumption stops, severe emotional 
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and physical consequences are felt, including withdrawal symptoms.  It is not the case 
that anyone who imbibes alcohol is destined to follow this pattern and become dependent 
on alcohol.  Genetic makeup plays a major role in the risk for developing dependence, 
which will be discussed in detail later. 
CELLULAR AND MOLECULAR CONSEQUENCES 
Cell-cell communication between neurons in the brain allows the brain to store 
information, regulate basic body functions and direct behavior.  Neurons communicate 
via neurotransmitters and their receptors.  Neurotransmitters are small molecules or 
peptides that are released by a pre-synaptic neuron, travel across the synapse (the small 
gap between neurons) and bind specific receptors on the post-synaptic neuron.  A series 
of molecular events follow inside the post-synaptic cell, depending on what type of 
receptor is activated.   
Alcohol disrupts the normal homeostasis of neuronal communication by altering 
the location and production of neurotransmitters, receptors, transporters, signaling 
molecules, second messengers and transcription factors (For a review, see (Diamond and 
Gordon, 1997)).  Alcohol affects several key neurotransmitters and neuromodulators in 
the brain, including gamma-aminobutyric acid (GABA) (Mihic and Harris, 1997), 
glutamate (Gonzales and Jaworski, 1997), dopamine (Di Chiara, 1997), serotonin 
(Lovinger, 1997) and opioid peptides (Froehlich, 1997).  Two of the more well-studied 
systems are glutamate and the NMDA receptor and GABA and the GABAA receptor.  
Glutamate is the major excitatory neurotransmitter in the brain and GABA is the major 
inhibitory one.  Alcohol inhibits neuronal communication by decreasing the excitatory 
actions of glutamate and increasing the inhibitory actions of GABA (For a review see 
(Diamond and Gordon, 1997)).  NMDA receptor activity is altered by chronic alcohol 
consumption and studies have linked altered receptor activity to fetal alcohol syndrome, 
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physical dependence and cognitive impairment (Gonzales and Jaworski, 1997).  Both 
acute and chronic alcohol exposure can alter GABAA receptor function and several 
studies have shown that GABAA receptors may play a role in the development of alcohol 
tolerance and dependence (Mihic and Harris, 1997).  Dopamine is a neuromodulator 
involved in motivation and reinforcement.  Alcohol increases the firing rate of dopamine 
neurons in the VTA of the midbrain thereby stimulating the release of dopamine in the 
Nacc.  The activation of this reward pathway by alcohol contributes to the compulsion to 
drink again (Di Chiara, 1997).  Serotonin and its receptors have been implicated in 
alcohol consumption and reinforcement (Valenzuela, 1997).  Serotonin receptor 
antagonists reduce alcohol drinking in certain animal models (Diamond and Gordon, 
1997) and specific receptor subtypes can stimulate DA release in the Nacc when 
activated by alcohol (Valenzuela, 1997).  Opioid peptides have also been implicated in 
alcohol consumption and reinforcement (Froehlich, 1997).  Opioid system inhibitors 
decrease alcohol self-administration in animals and alcohol consumption in humans 
(Froehlich, 1997).  Acute alcohol consumption stimulates the release of endogenous 
opioids (Gianoulakis, 2001) that bind to opioid receptors, which in turn activates the 
mesolimbic DA reward pathway (Herz, 1997). 
In addition to altering communication between cells and brain regions, alcohol 
also alters communication within cells.  When neurotransmitters bind to metabotropic 
receptors on the surface of neurons, a signal transduction cascade is begun inside the 
neuron.  Molecules called second messengers, kinases and phosphatases (the latter two 
alter protein phosphorylation) are a part of this signaling cascade.  Some of these signals 
are transmitted to the nucleus to regulate gene transcription.  For example, many 
transcription factors are regulated by phosphorylation.  Acute and chronic exposure to 
alcohol causes cyclic AMP (cAMP) (a second messenger) levels to increase and 
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decrease, respectively.  cAMP regulates the activity of protein kinase A (PKA), and it too 
has been implicated in mediating cellular responses to alcohol.  Numerous studies have 
demonstrated that the activity of another kinase, protein kinase C (PKC), is also affected 
by alcohol (Diamond and Gordon, 1997).  Acute alcohol exposure has been shown to 
cause an increase in CREB (a transcription factor) phosphorylation and CRE-mediated 
gene transcription, whereas chronic exposure decreased CREB activation (Pandey et al., 
2005).  Partial deletion of the CREB gene has been shown to increase alcohol drinking in 
mice (Pandey et al., 2004).  Some members of the fos and jun families of immediate early 
genes are activated in response to acute alcohol administration in rodents (Rhodes and 
Crabbe, 2005).  By altering transcription factors such as fos and jun, alcohol can 
indirectly affect the expression of hundreds of other genes as well. 
Finally, a number of studies have shown that several proteins have alcohol-
sensitive binding sites.  Mihic et al. demonstrated that an alcohol binding pocket exists 
between transmembrane segments 2 and 3 (TM2 and TM3) of the GABAA and glycine 
receptors’ subunits (Mihic et al., 1997).  Furthermore, it was discovered that the size of 
the amino acid (and consequently, the binding pocket itself) at a specific site on TM2 was 
directly proportional to the magnitude and direction of alcohol’s effects (Ye et al., 1998).  
Two amino acid sites on the α2β4 nicotinic acetylcholine receptor (nAChR) were found 
to be sensitive to short- and long-chain alcohols, producing enhancement or inhibition of 
the receptor, respectively (Borghese et al., 2003).  In addition, alcohol potentiation of DA 
transporter (DAT) function can be abolished by introducing specific amino acid 
mutations in the second intracellular loop between TM2 and TM3 of the protein (Maiya 
et al., 2002). 
Based on all of these studies, it is clear that alcohol affects a wide range of 
receptors and neurochemical systems in the brain.  The brain starts to adapt to these 
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molecular and cellular alterations almost immediately.  The current hypothesis is that 
over time, some of these changes become permanent.  Stable changes in receptor amount, 
intracellular signaling, projections between brain regions and ultimately, basic brain 
function are thought to be caused, in part, by changes in gene expression.  Stable 
alterations in gene expression are thought to contribute to the manifestations of alcohol 
dependence, including tolerance, withdrawal symptoms and the ultimate loss of control 
felt with regard to alcohol consumption (Hyman and Malenka, 2001; Nestler, 2001; 
Nestler and Landsman, 2001). 
THE PREFRONTAL CORTEX (PFC) 
The prefrontal cortex (PFC) in humans is located in the frontal lobes, anterior to 
the motor cortices.  The PFC is responsible for higher cognitive thinking, such as 
problem solving, critical thinking, planning, judgment and impulse control (Funahashi, 
2001).  The ability to make appropriate decisions regarding everyday behavior comes 
from the PFC’s ability to maintain a “working memory” (Baddeley, 1986).  When faced 
with a new environment, the PFC recalls a number of stored memories simultaneously, 
guiding the decision-making process and preventing an inappropriate behavioral response 
(Krawczyk, 2002).  The PFC has been defined in the rat, both structurally and 
functionally (Heidbreder and Groenewegen, 2003; Uylings et al., 2003).  Similar to 
humans, the rat PFC has been implicated in working memory, initiation of response and 
management of emotions (Heidbreder and Groenewegen, 2003).  Topographically, the 
mouse PFC closely resembles that of the rat (Guldin et al., 1981), although less is known 
about its function.  Insight into the molecular and cellular characteristics of the mouse 
PFC, however, has been gained through studies of gene expression (Kerns et al., 2005) 
and neurotransmitter release (Ihalainena et al., 1999; Douglas et al., 2001, 2002). 
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Both short and long-term alcohol abuse have been shown to damage the PFC and 
surrounding areas in humans and rats.  The frontal lobes are particularly susceptible to 
the effects of chronic alcohol abuse in humans, where brain shrinkage as well as a loss of 
cortical neurons have been observed (Kril et al., 1997; Kril and Halliday, 1999).  Acute 
alcohol exposure was found to impair planning and spatial recognition in social drinkers 
(Weissenborn and Duka, 2003).  In rodent models of binge drinking, neurodegeneration 
was observed in the olfactory bulbs and selected regions of the cerebral cortex (piriform 
cortex, perirhinal cortex, entorhinal cortex and dentate gyrus) (Obernier et al., 2002b). 
The PFC is an important brain region with which to study the development of 
dependence due to its connection to the mesocorticolimbic DA pathway.  DA is released 
into the PFC upon activation of the VTA by alcohol (Bowirrat and Oscar-Berman, 2005).  
The increase in DA is associated with feelings of euphoria, thereby reinforcing the 
positive effects of alcohol exposure.   
The effects of alcohol exposure on gene expression in the mouse PFC has only 
recently been explored (Kerns et al., 2005).  It is obvious that this brain region is affected 
in many ways by alcohol consumption in humans.  Deficits in decision-making and 
judgment along with feelings of euphoria and reward all contribute to the motivation to 
drink again, even after negative consequences are felt.  Evidence suggests that even a few 
binge drinking episodes can alter brain function both physically and mentally, priming 
the brain for an eventual state of alcohol dependence.  By identifying gene expression 
changes in the mouse PFC after acute alcohol administration over time, insight may be 
gained into the neuroadaptation occurring in this part of the reward pathway to enhance 
reinforcement and contribute to the development of dependence. 
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Genetics of alcohol dependence 
Alcohol dependence is a complex polygenic disease.  The risk for becoming 
dependent on alcohol is influenced by both environmental factors and genetic makeup.  
Several other common diseases, such as cancer, heart disease, diabetes and obesity are 
also complex in nature.  The prevalence, severity and complexity of all these diseases 
make the science behind them difficult to solve.  One of the most challenging obstacles 
faced when trying to identify genes that contribute to a disease phenotype is the fact that 
hundreds of genes may only individually exert a small effect on the disease.  Alcohol 
dependence is no exception. 
HUMAN 
Several twin and adoption studies have explored the genetic contribution to 
alcohol dependence.  Studies of adoptees raised apart from affected and unaffected 
parents found the disease to be about 40% heritable (Goodwin et al., 1973; Cloninger et 
al., 1981).  Twin studies using both identical and fraternal same sex twins (male and 
female), found a range of genetic contribution, from 35% to 64% (Pickens et al., 1991; 
Kendler et al., 1992; Heath et al., 1997; Kendler et al., 1997). 
Based on the results of these studies, the Collaborative Studies on Genetics of 
Alcoholism (COGA) was founded in 1989 to identify and map susceptibility genes for 
alcohol dependence in humans (Begleiter et al., 1995).  With approximately 300 families 
consisting of greater than 3000 individuals (Edenberg, 2002), the COGA has provided 
alcohol researchers with a large genetic human “database” with which to perform 
candidate gene and linkage studies to identify genes and markers that may be associated 
with increased risk for developing dependence.  For example, electroencephalographic 
(EEG) patterns and specific personality traits are two heritable endophenotypes (a trait 
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that has been shown to be associated with a specific condition) that have been shown to 
be correlated to alcohol use (Reich et al., 1999).  The amplitude of the P3 event-related 
brain potential (ERP) and four stable quantitative dimensions of personality (Cloninger et 
al., 1993) can be measured and potentially linked to chromosomal regions, thereby 
indicating where susceptibility genes for dependence reside (Reich et al., 1999).  EEG 
patterns and personality traits have been used to identify genetic linkage on chromosomes 
2, 6, 5 and 13 (Begleiter et al., 1998) and chromosome 8 (Cloninger et al., 1998), 
respectively. 
Alcohol dependence is a human disease with characteristics that are difficult to 
fully recapitulate in other organisms.  However, linkage studies in humans often lack the 
power to find the definitive loci associated with a particular trait.  Therefore, genetic 
studies using animal models of alcohol dependence serve as complementary methods to 
human studies in detecting the genes that may contribute to alcohol dependence. 
MOUSE 
The mouse genome was recently sequenced (Waterston et al., 2002), allowing 
researchers to directly compare the genetic makeup of the mouse to human (Lander et al., 
2001; Venter et al., 2001).  As of 2002, the mouse genome contained about 30,000 genes, 
of which 99% have direct counterparts in humans.  Therefore, genes found in the mouse 
to be affected by alcohol or predisposing to dependence may directly correlate with genes 
in human.  The mouse has become a valuable tool with which to study the genetics of 
alcohol dependence due to its ability to model specific phenotypes of the disease and the 
wide variety of experimental techniques that exist to study those phenotypes. 
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Experimental techniques 
Mice have been used to study the inheritance of traits for at least 3000 years 
(Beck et al., 2000).  In the early 1900s, mice started to become a valuable tool in the 
laboratory to study inheritance.  Clarence C. Little established the first inbred strain of 
mouse.  An inbred strain is created by performing brother x sister matings for 20 or more 
consecutive generations (Beck et al., 2000).  Now, over 450 inbred strains exist (Beck et 
al., 2000).  They are an invaluable tool to genetic researchers because all of the same sex 
mice in an inbred strain are genetically identical to each other and 98.6% of the loci in 
each mouse are homozygous (Beck et al., 2000).  This means that experiments done with 
a particular inbred strain from 1980 in Portland, Oregon can be compared to data from 
experiments performed in 2005 in Austin, Texas.   
Another breeding technique that started being utilized in addiction studies in the 
1940s is selective breeding (Crabbe, 2002a).  Heterogeneous mice can be screened for 
specific behaviors and then bred according to the intensity of those behaviors.  So, all of 
the mice with the most or least severe form of the trait are bred (Grahame, 2000).  
Furthermore, selected lines of mice can be inbred as well to make them genetically 
identical. 
Alcohol dependence is a quantitative trait, meaning multiple genes contribute to 
the disease and the severity in people varies continuously across a population, often 
following a normal distribution (Crabbe et al., 1994).  Regions of chromosome that 
contain a gene or genes influencing a quantitative trait are called Quantitative Trait Loci 
(QTL) (Grisel, 2000).  A technique called QTL analysis is used to identify chromosomal 
regions that are correlated with a specific trait.  The development of Recombinant Inbred 
(RI) strains has made QTL analysis much easier.  The BxD RI strains were created by 
crossing C57BL/6J (B6) mice with DBA/2J (D2) inbred strains of mice (Taylor, 1978).  
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In a B6 x D2 cross, all of the F1s are identical to each other, possessing one allele from 
the B6 mouse and one from the D2 mouse.  In order to create genetic diversity, the F1s 
are crossed.  As a result of recombination, individual F2s contain a unique pattern of 
parental alleles.  Brother-sister pairs of F2s are mated to create inbred strains of each of 
the F2s.  Therefore, each inbred strain has a unique combination of B6 and D2 alleles 
fixed in a certain place on the chromosome.  26 inbred strains were created using this 
technique, with over 1300 polymorphic alleles genotyped to date (Grisel, 2000).  A 
correlation between genotyped alleles and  specific biochemical or behavioral responses 
are used to identify a QTL (Tabakoff and Hoffman, 2000).  Once a QTL has been 
identified, the next step is to identify candidate genes within the QTL that are influencing 
the trait of interest directly or through epistasis. 
The mouse genome can be manipulated to study specific genes of interest by 
creating transgenic, knockout and knock-in mice.  To create a transgenic mouse, a foreign 
gene is introduced into the mouse genome, which often leads to an over-expression of the 
mRNA and protein product of the inserted gene.  Although it is possible to control the 
timing and/or location of the gene’s expression by using a specific promoter, it is 
impossible to predict where the gene will be introduced into the genome.  The transgene 
can randomly insert anywhere and may disrupt other genes, promoters or intron/exon 
boundaries (Bowers, 2000).  To create a knockout or knock-in mouse, the gene of interest 
is mutated to render it non-functional (knockout) or alter its function from wild type 
(knock-in).  It is then inserted into the genome at its normal location on the chromosome 
using targeted mutagenesis.  If the wild-type version of the gene is vital to development, 
the mouse may not live to adulthood (Bowers, 2000). 
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Models of alcohol-related behavior 
Alcohol dependence is a disease that only truly affects humans.  Therefore, 
humans are theoretically the best subjects with which to study the disease and its genetic 
component.  However, it is not possible to perform certain types of experiments using 
humans as the subjects.  The mouse offers a viable alternative, due to its short gestation 
period, size, availability and known genome that can be manipulated with relative ease.  
Although no mouse model exists that fully recapitulates all aspects of alcohol 
dependence, many alcohol-related traits have been modeled and studied successfully in 
mice using inbred strains, selected lines or genetically altered mice. 
A difference in alcohol preference was observed between the B6 and D2 inbred 
strains in 1959 by McClearn (McClearn, 1959).  The B6 mice preferred drinking a 10% 
alcohol solution over water while the D2 mouse avoided the alcohol solution.  A 
correlation between alcohol consumption and withdrawal severity has been shown in 
both inbred strains and selected lines.  The mice that drink more tend to have less severe 
withdrawal symptoms and vice-versa (Metten et al., 1998).  Selected lines of mice have 
been bred to study initial sensitivity to alcohol via its hypnotic effects (Long-Sleep (LS) 
and Short-Sleep (SS)), severity of withdrawal from chronic alcohol exposure 
(Withdrawal Seizure-Prone (WSP) and Withdrawal-Seizure Resistant (WSR) mice), 
degree of acute functional tolerance to ataxia caused by alcohol exposure (High/Low 
Acute Functional Tolerance (HAFT1, -2 and LAFT1, -2) and preference for a 10% 
alcohol solution over water (High/Low Alcohol-Preferring mice (HAP1, -2 and LAP1, -
2)) (Crabbe et al., 1994). 
QTL analysis has been used in combination with the BxD RI strains to identify 
QTL for alcohol preference drinking on chromosomes 1, 2, 4 and 9 and acute alcohol 
withdrawal on chromosomes 1, 4 and 11 (Crabbe et al., 1999).  Other QTL for chronic 
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alcohol withdrawal, conditioned taste aversion, conditioned place preference, tolerance to 
the rotarod and hypothermia have also been identified (Crabbe, 2002b).   
Several transgenic and knockout mice have been created to study the effects of 
specific genes on alcohol-related phenotypes.  Some of the genes chosen for study were 
5-HT3 receptor, neuropeptide Y, dopamine D1 and D2 receptors, fyn kinase, protein 
kinase A and C and a selection of GABAA receptor subunits (Bowers, 2000; Boehm et 
al., 2004). 
What all of these studies demonstrate is that there is a clear genetic component to 
many if not all alcohol-related phenotypes.  All of the models used to study these 
phenotypes can give insight into the genetics behind them, and hopefully by extension, 
the genes contributing to the development of alcohol dependence.  Ideally, given the 
polygenic nature of the disease, these mouse models would be combined with other 
techniques, such as gene expression microarrays, to increase the number of genes studied 
at once. 
C57BL/6J (B6) and DBA/2J (D2) strains 
Two of the most commonly used inbred strains of mice are B6 and D2.  The D2 
strain was the first inbred strain created, produced by Clarence Little in 1909 (Silver, 
1995).  The B6 strain was created soon after D2.  As with all inbred strains, due to their 
fixed genetic makeup, B6 and D2 mice have some abnormal characteristics, such as a 
high susceptibility to diet-induced obesity (B6), late-onset hearing loss (B6), high-
frequency hearing loss (D2) and progressive eye abnormalities (D2) (For more 
information, see http://www.jax.org).  Fortunately for alcohol researchers, they have 
divergent phenotypes in many alcohol-related traits as well.  It was McClearn who first 
noticed in 1959 that the B6 strain preferred to take nearly all of its daily fluid from a 10% 
alcohol solution, as opposed to tap water, and that the D2 mouse was just the opposite 
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(McClearn, 1959).  One of the most striking differences between these two strains is their 
susceptibility to physical dependence, as evidenced by withdrawal symptoms following 
alcohol removal.  B6 mice experience extremely mild withdrawal symptoms, while D2 
mice experience severe withdrawal symptoms (Crabbe et al., 1983; Metten and Crabbe, 
1994).  Alcohol withdrawal severity also varies widely in human alcoholics, with 
manifestations ranging from mild insomnia to delirium tremens or death (Saitz, 1998). 
The B6 and D2 strains are easily obtainable, commonly used mice that differ 
greatly in alcohol preference and withdrawal severity, making them ideal models with 
which to study the genetics of alcohol dependence. 
Gene expression and alcohol dependence 
The sequencing of the human genome was one of the most important scientific 
achievements of the last 100 years (Lander et al., 2001; Venter et al., 2001).  Knowing 
the sequence of nucleotides along each chromosome, however, is only the first step in 
understanding how those nucleotides combine to form genes (and ultimately, how those 
genes function in the cell).  The central dogma of molecular biology is that DNA is 
transcribed to mRNA (genes), which is translated to protein.  It is estimated that the 
human genome contains 25,000 (protein coding) genes (IHGSC, 2004), a much smaller 
number than the once thought 100,000 genes.  On average, each gene is translated into 2-
3 different proteins, a consequence of alternative splicing.  Differential gene expression 
in cells at various stages of development and throughout life is the mechanism 
responsible for specific cell types, tissues and organs in the body. 
GENE EXPRESSION DETECTION AND ANALYSIS 
The combination of gene expression changes occurring in a cell at any given time 
can be referred to as its gene expression profile.  Alterations in gene expression profiles 
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during the normal stages of development, as a result of a diseased state or due to an 
environmental stimulus can give insight into the types of genes working in concert to 
produce a particular phenotype.  Gene expression analysis can be used to study all of the 
following phenomena:  1) What are the gene expression differences between the normal 
or unaltered state of one type of cell, tissue, organ or organism versus another?  Examples 
include:  a muscle cell versus a neuron, the liver versus the brain and a chimp versus a 
human.  2) What are the gene expression differences between the normal or unaltered 
state of one type of cell, tissue, organ or organism versus the altered or diseased state?  
Examples include:  a healthy cell versus a cancerous one, the brain of a non-alcohol 
drinker versus the brain of a chronic alcoholic and a wild type mouse versus a transgenic 
or knock-out.  3) What are the gene expression differences between the normal or 
unaltered state of one type of cell, tissue, organ or organism versus one that has been 
exposed to some type of insult or treatment?  Examples include:  healthy tissue versus 
tissue that has been exposed to a deleterious or potentially beneficial drug.  4) What are 
the gene expression differences between the normal or unaltered state of one type of cell, 
tissue, organ or organism at time point A versus time point B?  Examples include:  the M 
phase versus the S phase of the cell cycle and a fetal cell versus an aged cell (Stears et al., 
2003).  Identifying what genes are regulated by all these processes is the first step in 
understanding the mechanisms by which they are regulated and generating hypotheses 
about how and why those mechanisms create the phenotype of interest.  
Non-microarray methods 
A variety of methods are available to study gene expression.  Some methods such 
as Northern blot analysis, RNase protection assay, Quantitative Reverse Transcription-
PCR (RT-PCR), real time RT-PCR and in situ hybridization detect the expression of one 
(or a few) gene(s) at a time; while others can detect the expression of hundreds or 
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thousands of genes simultaneously, including mRNA Differential Display (DD), Serial 
Analysis of Gene Expression (SAGE), subtractive hybridization and microarray analysis.   
In Northern blot analysis, RNase protection assay and in situ hybridization a 
labeled (with radioactivity or chemiluminescence) RNA or cDNA probe is generated 
from the gene(s) of interest.  The probe is then hybridized to the sample RNA which is 
immobilized on a blot transferred from an electrophoretic gel (Northern blot analysis) 
(Alwine et al., 1977; Princivalle et al., 2005), in a solution containing RNases (RNase 
protection assay) (Horii, 1996) or within a slice of tissue (in situ hybridization) (Gall and 
Pardue, 1969; Hofler et al., 1998; Princivalle et al., 2005).  In quantitative RT-PCR 
(Freeman et al., 1999; Joyce, 2002) or real-time RT-PCR (Bustin et al., 2005; Wong and 
Medrano, 2005), primers are generated for the gene of interest, the RNA samples are 
reverse transcribed and the cDNA is amplified.  The amount of PCR product reflects the 
expression level of the gene of interest in the original RNA samples.  Although the same 
amount of starting material is amplified, the amplification efficiency of different samples 
can vary, causing problems with quantification.  There is no way to account for this 
inequality of efficiency in quantitative RT-PCR.  However, in real-time PCR, a third 
probe is generated that is tagged with a fluorescent label, thereby allowing the 
amplification step to be visualized and the PCR product to be more accurately measured.  
All of the discussed methods are semi-quantitative (Cunningham, 2001). 
Subtractive hybridization, SAGE and mRNA DD are three methods that have the 
benefit of not only being able to detect the expression of hundreds of genes at once, but 
also the ability to detect novel transcripts.  A sequence specific probe is not used; 
therefore no prior knowledge of a gene or gene sequence is necessary for these 
techniques.  In subtractive hybridization, two RNA samples are combined and common 
transcripts hybridize together.  These common transcripts are subtracted out of the mix, 
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leaving only the differentially expressed genes.  A cDNA library is constructed from the 
unique genes.  In SAGE, the differentially expressed transcripts are reverse transcribed, 
cleaved and ligated together to form a single long piece of DNA that can easily be 
sequenced to determine gene identity (Cunningham, 2001).  mRNA DD is the most 
commonly used method of the three.  It was developed by Liang and Pardee in 1992 
(Liang and Pardee, 1992).  In DD, RNA samples are reverse transcribed into cDNA, 
which is then PCR amplified using a unique set of primers.  The 3’ primer is an anchored 
T-mer that contains 11 Ts and a single base anchor (A, G or C) at the primer’s 3’ end.  
The 5’ primer is one of 80 13-mers of arbitrary sequence (Liang and Pardee, 1998).  Each 
RNA sample is therefore amplified 240 times.  This unique design should statistically 
represent the majority of expressed eukaryotic mRNAs in a cell.  The distance separating 
the 3’ primer from the annealing location of the 5’ primer varies, usually producing PCR 
products of 100-500 base pairs in length (Liang and Pardee, 1992).  The PCR products 
are resolved on a denaturing polyacrylamide gel and appear as multiple bands of different 
sizes in each lane.  By comparing the location (size), presence (or absence) and intensity 
of bands in different samples, genes that are differentially expressed between the samples 
can easily be detected.  Radioactively labeled dATP is added to the mix of dNTPs so that 
the bands can be visualized on the gel.  Differentially expressed genes are excised from 
the gel and sequenced to determine gene identity.  DD has several advantages over other 
gene expression detection methods, including:  1) DD can detect previously unidentified 
transcripts, 2) DD can detect both rare and abundant transcripts, 3) DD can detect 
insertions and deletions in transcripts and 4) DD can theoretically detect every 
differentially expressed gene between RNA samples, based on the use of the arbitrary and 
anchored T-mer primers (For more detail, see http://www.genhunter.com).  Although 
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these advantages do make DD an attractive method for gene expression detection, DD 
can be very time consuming and difficult to perform well.   
Microarray analysis is a fourth method of gene expression detection that has 
continued to gain popularity since its inception 11 years ago.  It is discussed in the next 
section. 
Microarray analysis 
In 1995, a group of scientists at Stanford published a paper using a new method of 
gene expression detection they had developed called cDNA microarray analysis that 
would revolutionize the way high-throughput gene expression profiling was performed 
(Schena et al., 1995).  They printed 48 cDNAs from Arabidopsis thaliana onto a glass 
microscope slide, isolated RNA from a sample of Arabidopsis and reverse transcribed it 
to make cDNA, labeled the cDNA with a fluorescent tag and hybridized it to the 
microscope slide to determine which genes were expressed in the original Arabidopsis 
RNA sample.  Since that time, cDNA microarrays have expanded to include as many as 
50,000 cDNAs printed on a single glass microscope slide.  In addition, several variants of 
cDNA microarray analysis have been developed and include oligonucleotide, 
carbohydrate and protein arrays to measure expression, Single Nucleotide Polymorphism 
(SNP) arrays to screen for DNA mutations and polymorphisms, Comparative Genomic 
Hybridization (CGH) arrays identify difference in DNA copy number and Chromatin 
ImmunoPrecipitation (ChIP) arrays to measure DNA methylation and histone acetylation 
(Goldsmith and Dhanasekaran, 2004). 
cDNA microarray analysis was originally developed to identify gene expression 
differences between two (or more) samples of RNA.  The basic steps of cDNA 
microarray analysis are the following:  1) A collection of cDNAs (can be known genes or 
expressed sequence tags (ESTs)) are placed on a solid support (usually a glass 
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microscope slide or nylon membrane) at defined locations, 2) RNA is isolated from cells, 
tissue or an organism and reverse transcribed to create cDNA, 3) The cDNA is labeled 
(usually with a fluorescent tag or radioactivity) and allowed to hybridize to the solid 
support, 4) Based on the signal intensity of each cDNA spot on the array, information is 
gained about the amount and type of genes expressed in the original RNA sample.  
Usually, the cDNA hybridized to the slide is from two different sources of RNA.  The 
two samples that are co-hybridized represent one of two different experimental designs:  
1) A direct or “within slide” comparison, where both samples are experimental – one is a 
control (sample A) and the other is treated (sample B) or 2) An indirect or “between 
slide” comparison, where one sample is experimental (sample A or sample B) and the 
other is a reference (Yang and Speed, 2002).  The second experimental design that 
employs the use of a reference is ideal for large scale studies that involve many treatment 
groups for example.  Theoretically, an unlimited number of experimental samples could 
be included in the design and all of them would be comparable if they had all been 
hybridized to the same reference sample.  An ideal reference sample would be one that is:  
1) homogenous, 2) of unlimited supply and 3) contains every gene or EST printed on the 
microarray (so that the reference channel always has an intensity associated with it) 
(Churchill, 2002). 
For cDNA microarrays that use fluorescently labeled cDNA and glass microscope 
slides as the solid support, the co-hybridized RNA (cDNA) samples must be 
fluorescently labeled with two different dyes.  The most commonly used dyes are 
cyanine-3 (Cy-3) and cyanine-5 (Cy-5).   After the fluorescently labeled cDNA samples 
are co-hybridized to the array, the array must be scanned using a machine with a pair of 
lasers that excite and detect the emissions of the Cy-3 and Cy-5 dyes.    The cDNA spots 
on the scanned array image show up as green (Cy-3), red (Cy-5) or yellow (Cy-3 and Cy-
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5 together), which is indicative of the gene expression profile of each of the co-
hybridized samples (Figure 1.2).  The color of the spot indicates in which of the two 
samples the gene was more highly expressed.  For example, if sample A was labeled with 
Cy-5 and sample B with Cy-3 (Figures 1.2 and 1.3), then a red spot would indicate that 
the cDNA in that spot hybridized only to cDNA in sample A and that that particular gene 
or EST was not present in sample B.  A green spot would indicate just the opposite—that 
the cDNA in that spot hybridized only to cDNA in sample B and that that particular gene 
or EST was not present in sample A.  A yellow spot would indicate that that gene or EST 
was present in equal amounts in both sample A and B and a spot with no color would 
indicate that that gene or EST was not present in either sample A or B (Figures 1.3 and 
1.4). 
Figure 1.2:  cDNA microarray overview.  Two RNA samples (A and B) are reverse 
transcribed and labeled with Cy-5 and Cy-3 (respectively).  They are co-hybridized to a 
microscope slide containing thousands of cDNA clones that have been printed with a 
robot.  Lasers excite the dyes and detect their emission to produce an image with colors 
that indicate which genes were differentially expressed and to what level (between the 
two RNA samples). 
 
 
(Duggan et al., 1999) 
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Figure 1.3:  Interpretation of colors on a scanned microarray image.  The color of 
the spot indicates in which of the two samples the gene was more highly expressed.  If 
sample A was labeled with Cy-5 and sample B with Cy-3, then a red spot would indicate 
that the cDNA in that spot hybridized only to cDNA in sample A and that that particular 
gene or EST was not present in sample B.  A green spot would indicate just the 
opposite—that the cDNA in that spot hybridized only to cDNA in sample B and that that 
particular gene or EST was not present in sample A.  A yellow spot would indicate that 
that gene or EST was present in equal amounts in both sample A and B. 
  
 
(Nuwaysir, 2000) 
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Figure 1.4:  Example of a cDNA microarray.  A single block (over 500 genes) of a 
scanned microarray slide is shown.  To continue with the examples using samples A and 
B from Figures 1.2 and 1.3, sample A is B6 reference and is labeled with Cy-5 (red) 
while sample B is D2 male cerebellum at the 0 hour time point after chronic alcohol 
exposure (72 hours in alcohol vapor chamber) and is labeled with Cy-3 (green).  A 
spectrum of colors and intensity is present, indicating many genes are differentially 
expressed between these two samples. 
 
 
(A.E. Berman; Genisphere 3DNA Array 350 kit; August 20, 2003) 
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The gene identification, color and intensity information is gathered for each spot 
on the array using software designed specifically for that purpose.  The intensity value of 
each spot can range from 0 to 65,535 intensity units (Stears et al., 2003) per channel (red 
and green).  The background-subtracted red and green intensity values from each spot are 
saved in a tab delimited file for further processing.  The expression level for each gene or 
EST on the array is represented as a ratio of red to green or green to red, depending on 
the experimental design.  When a reference sample is used, the intensity value of the 
reference channel is the denominator in the ratio.  The expression ratios are often log 
(base 2) transformed because this allows up- and down-regulated genes to be treated 
equally—the magnitude of regulation is symmetric on either side of zero.  For example, a 
ratio of 2:1 represents a two-fold increase in expression whereas a ratio of 1:2 represents 
a two-fold decrease.  The quotient of 2:1 is 2, but the quotient of 1:2 is 0.5.  They both 
represent the same absolute value of fold change but are not symmetrical with respect to 
zero.  However, if the ratios are log transformed, 2:1 becomes 1 and 1:2 becomes -1.  
These values are symmetrical with respect to zero (Quackenbush, 2002; Goldsmith and 
Dhanasekaran, 2004). 
In order to identify the genes that are differentially expressed on the arrays, it is 
necessary to separate technical variability from true biological differences.  Technical 
variability can be reduced by excluding low quality or un-resolvable spots from further 
analysis, normalizing the data (see the Materials and Methods section for a discussion 
about array normalization) and filtering out low intensity or outlier values.  Once a set of 
genes exists that truly represents the biology of the original RNA samples, a series of 
statistical tests, visualization tools and dimension reducers can be applied to discover the 
gene expression profiles of those samples (Quackenbush, 2001; Stears et al., 2003). 
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The ultimate goals of microarray analysis extend beyond lists of differentially 
expressed genes.  Identifying the gene expression profiles of a particular phenotype or 
condition of an organism is only the first step in understanding the biology behind that 
phenotype or condition.  Genes can be grouped by their cellular function or location, by 
common transcription factor binding sites or by the biological pathways to which they 
belong—all to gain a better understanding of how hundreds of concomitant 
transcriptional changes translate into phenotypic changes.  For the research scientist, gene 
expression arrays create innumerable hypotheses to test; for the clinician, they can 
identify potential disease markers, differentiate between a healthy cell and a cancerous 
one or elucidate the biochemical basis of a drug response (Stears et al., 2003).  It is 
conceivable that drugs could be tailored to specific subsets of the population, depending 
on their gene expression profiles…or that patients could purchase home testing kits to 
determine if they are at risk for breast cancer or cystic fibrosis (Stears et al., 2003).  
Several studies have already demonstrated the successful use of expression arrays to:  1) 
Identify prognostic biomarkers for breast cancer and predict response to therapy (Jeffrey 
et al., 2005), 2) Differentiate between patients with cardiovascular disease versus healthy 
patients (Archacki and Wang, 2004), 3) Screen patients for possible Human Papilloma 
Virus (HPV) infection (An et al., 2003; Kim et al., 2003) and 4) Identify the virus 
responsible for Severe Acute Respiratory Syndrome (SARS) (Wang et al., 2002; Ksiazek 
et al., 2003; Rota et al., 2003). 
Of all the gene expression detection methods available, microarrays are the most 
attractive due to the fact that:  1) Tens of thousands of genes can be screened 
simultaneously, 2) Many RNA samples can be screened in a relatively short amount of 
time, 3) Less than 500ng of starting material is required, 4) Sophisticated instrumentation 
for manufacture, detection and data analysis is available, 5)  The technology for 
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manufacturing, hybridizing and scanning the arrays, processing the data  and analyzing 
the data is constantly being improved and updated and 6)  Hundreds of types of 
microarrays are commercially available (Stears et al., 2003). 
APPLICATION OF GENE EXPRESSION METHODS TO STUDY ALCOHOL DEPENDENCE 
Studies using non-microarray methods 
It is well established that alcohol dependence is about 50% heritable (Goodwin et 
al., 1973; Cloninger et al., 1981; Pickens et al., 1991; Kendler et al., 1992; Heath et al., 
1997; Kendler et al., 1997).  One approach used to identify the genetic factors that may 
contribute to the development of the alcohol dependence is to study gene expression. 
Individual genes have been identified as differentially expressed between 
(alcohol-naïve) inbred strains and selected lines of mice and rats that are divergent in 
alcohol-related phenotypes.  Both neuropeptide Y (NPY) and alpha-synuclein genes were 
identified as differentially expressed between the naïve inbred alcohol-preferring (iP) and 
inbred alcohol-nonpreferring (iNP) rat lines.  NPY expression was decreased in several 
brain regions of the iP versus iNP rat (Spence et al., 2005), whereas alpha-synuclein 
expression was increased in the hippocampus of the iP versus the iNP rat (Liang et al., 
2003).  Three of the GABAA-receptor subunit genes (alpha-1, alpha-3 and alpha-6) were 
less expressed in naïve WSP mice compared to WSR mice (Buck et al., 1991; Keir and 
Morrow, 1994).   
Alcohol consumption in mice and rats alters gene expression as well.  After being 
fed an alcohol-containing liquid diet, the brains of WSP and WSR mice were compared 
for differences in gene expression of GABAA-receptor subunits.  A decrease in the alpha-
1 subunit gene was observed in the WSP line, but not the WSR line, whereas a decrease 
in the alpha-6 subunit gene was observed in the WSR line, but not the WSP line (Buck et 
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al., 1991).  The expression of microtubule-associated protein 2 (MAP2) gene  decreased 
in several brain regions of the alcohol-preferring AA (Alko Alkohol) rats after 16 months 
of voluntary alcohol consumption compared to control (Putzke et al., 1998).   
Both acute and chronic paradigms of alcohol exposure have been used to detect 
changes in gene expression.  Neural cell lines were used to identify three alcohol-
responsive genes that were up-regulated compared to control:  heat shock cognate 70 
(Hsc70) (Miles et al., 1991), tyrosine hydroxylase (TH) (Gayer et al., 1991) and 
dopamine beta-hydroxylase (DBH) (Hassan et al., 2003).  Metallothionein II (MT-II) 
gene was up-regulated in the brains of D2, A/J, BALB/cJ and B6 strains of mice after a 
single high injection of alcohol (acute paradigm) compared to control (Loney et al., 
2003).  Another study by the same group identified retinaldehyde binding protein 1 
(Rlbp1) gene as less abundant in the brains of alcohol-treated B6 and D2 strains 
compared to control and syntaxin 12 (Stx12) gene as less abundant in the brains of 
alcohol-treated D2 mice compared to control, again using a single high injection of 
alcohol (Treadwell et al., 2004).  Schafer et al. identified neuroendocrine-specific protein 
(NSP)/reticulon 1 (RTN1) gene as differentially expressed in the brain between the WSP 
and WSR lines of mice after chronic alcohol exposure (Schafer et al., 1998).  
Furthermore, this gene was found to be more highly expressed in the hippocampus and 
cortex of all alcohol-treated mice (WSP/WSR and B6/D2) over controls and less 
expressed in the cerebellum of WSP and D2 mice, but not WSR or B6, compared to 
controls (Schafer et al., 2001).  Prodynorphin (Pdyn) gene expression was increased 
during chronic alcohol withdrawal in several brain regions of WSP-1 mice (Beadles-
Bohling and Wiren, 2005). 
Finally, studies of chronic alcoholics also reveal differential brain gene 
expression.  Mitochondrial 12S rRNA gene was identified as more highly expressed in 
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the Nacc and hippocampus of post-mortem human alcoholic brains (compared to 
control), but not in several other regions tested (Fan et al., 1999).  hNP22 gene expression 
was increased in the superior frontal cortex of human alcoholics compared to controls 
(Fan et al., 2001). 
In all of the above studies, techniques like mRNA Differential Display, real time 
PCR, Northern blot analysis and in situ hybridization were used to identify differentially 
expressed genes.  The common theme among all of these techniques is that the amount of 
labor required to identify more than just a few differentially expressed genes is not time- 
or cost-effective.  Granted, many of these studies were “unbiased,” meaning candidate 
genes were not chosen to study based on previous knowledge about their involvement in 
alcohol dependence.  Given the complexity of the disease, it is novel to use models of 
dependence to search for new genes that could never have been intuited.  However, to 
search effectively for genes involved in a complex, polygenic disease such as alcohol 
dependence, fast high-throughput methods are ideal.  Microarray analysis has become an 
increasingly popular method to detect differential gene expression in models of alcohol 
dependence. 
Studies using microarrays 
A number of microarray studies have explored the genetics of predisposition to 
alcohol dependence using (alcohol-naïve) inbred strains and selected lines of mice and 
rats that are divergent in alcohol-related phenotypes.  Candidate genes for alcohol 
sensitivity (Xu et al., 2001) and acute functional tolerance (Tabakoff et al., 2003) were 
identified in the whole brains of mouse models for each (inbred long-sleep (ILS) and 
inbred short-sleep (ISS), high acute functional tolerance (HAFT) and low acute 
functional tolerance (LAFT), respectively) using microarrays.  The genetics of alcohol 
drinking was explored in a meta-analysis of microarray results from three selected lines 
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and six isogenic strains of mice that differ in voluntary alcohol consumption (Mulligan et 
al., 2006).  Genes were identified that may contribute to the development of alcohol 
tolerance by comparing the hippocampal transcription profile of inbred alcohol-preferring 
(iP) and -nonpreferring (iNP) rats (Edenberg et al., 2005).  Finally, two studies compared 
the transcription profile of brain regions involved in the reward pathway (cingulate 
cortex, nucleus accumbens, amygdala and hippocampus (Arlinde et al., 2004) and frontal 
cortex (Worst et al., 2005)) to search for alcohol preference genes using the alcohol-
preferring AA (Alko, alcohol) and alcohol-avoiding ANA (Alko, non-alcohol) rat strains. 
Gene expression changes elicited by alcohol can be explored using a wide range 
of organisms/models, from the simple to the complex.  Alcohol-related genes have been 
identified using simple systems of mammalian cells and Saccharomyces cerevisiae 
(yeast) coupled with microarray analysis.  Human neuroblastoma cells were treated with 
alcohol for three days to identify alcohol-sensitive genes.  42/6000 genes on the 
oligonucleotide array were up- or down-regulated by alcohol (Thibault et al., 2000).  
Cortical neurons isolated from B6 fetuses were treated with alcohol for five days and the 
isolated RNA was applied to a pathway-specific cDNA microarray containing 638 
clones.  Most of the differentially expressed genes were down-regulated (56) compared to 
only a few that were up-regulated (10) (Gutala et al., 2004).  Yeast cells were used to 
identify genes differentially expressed as a result of 30 minutes of alcohol stress.  About 
6% of the genes on the 6138 clone-containing cDNA array were up- or down-regulated 
(3% each) (Alexandre et al., 2001). 
As the models used move from single-celled to multi-cellular, phenotypes such as 
alcohol-related behavior can be considered in addition to alcohol-sensitive changes in 
gene expression.  Caenorhabditis elegans (nematode) was used as a model system to 
study the effects of acute alcohol administration on gene expression.  The nematode 
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displays similar behavioral responses to acute alcohol as does a mouse or human, mainly 
hypersensitivity, uncoordination and sedation.  The nematodes were exposed to alcohol 
for 15 minutes, 30 minutes and 6 hours.  In total, 230 genes on the cDNA array were 
affected by alcohol.  Most of the genes were up- or down-regulated at the later time point, 
as opposed to the earlier time points (Kwon et al., 2004). 
Several studies have used mouse and rat strains that diverge in alcohol-related 
behaviors to study the effects of alcohol administration on gene expression.  Daniels and 
Buck used cDNA microarrays to compare gene expression changes in the hippocampus 
of B6 and D2 mice after chronic (72 hour vapor chamber with 0 hour sacrifice) or acute 
(4 g/kg alcohol injection with 7 hour sacrifice) withdrawal (Daniels and Buck, 2002).  Of 
the 7634 clones on the cDNA array, 2% were differentially expressed in D2 and less than 
1% in B6 during chronic withdrawal (compared to control).  Less than 1% were 
differentially expressed in D2 during acute withdrawal (compared to control).  Upon 
functional classification of the differentially expressed genes, many were found to be 
associated with the Ras/mitogen-activated protein kinase (MAPK), Janus kinase/signal 
transducers and activators of transcription (JAK/STAT) and Akt/phophatidylinositol 3-
kinase (PI 3-kinase) signal transduction pathways.  Treadwell and Singh also explored 
the brain expression profiles of B6 and D2 mice after an acute injection of alcohol (6 
g/kg) (Treadwell and Singh, 2004).  They identified 61 genes (out of 24,000) that were 
differentially expressed six hours after alcohol exposure in one or both strains (compared 
to control).  The alcohol-related genes have roles in cell signaling, gene regulation and 
homeostasis/stress response.  Unlike the two previous studies, where the administration 
of alcohol resulted in a physically dependent mouse, the following study identified gene 
expression changes in the B6 and D2 mouse brain after a stimulating dose of alcohol.  
Kerns et al. examined the regions composing the brain’s reward pathway (nucleus 
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accumbens (Nacc), prefrontal cortex (PFC) and ventral tegmental area (VTA)) for 
differences in gene expression four hours after an acute injection of alcohol (2 g/kg) 
(Kerns et al., 2005).  They identified 307 alcohol-sensitive genes (out of 12,000) in the 
three brain regions of the B6 or D2 mice (compared to control).  The Nacc had the most 
gene changes (~78 in B6; ~90 in D2), followed by the PFC (~23 in B6; ~87 in D2) and 
VTA (~37 in B6; ~10 in D2)).  The regulated genes in each brain region belonged to 
discrete functional groups:  neuropeptide signaling and development in the Nacc, 
glucocorticoid signaling, neurogenesis and myelination in the PFC and retinoic acid 
signaling in the VTA.  Rimondini et al. subjected Wistar rats to repeated cycles of 
withdrawal and intoxication for a seven week period, followed by a three week recovery 
period (Rimondini et al., 2002).  After the three week recovery period, the rats consumed 
higher amounts of alcohol than before, as measured by a two-bottle choice paradigm.  
Microarray analysis was done on the cingulate frontal cortex and amygdala of the 
alcohol-exposed rats (versus control) following the three week recovery period (designed 
to be in parallel with the induction of alcohol preference in the rats given the two-bottle 
choice paradigm).  Gene expression changes were identified (19 in the cortex and 13 in 
the amygdala) that belonged to the following functional categories:  neurotransmission, 
signal transduction and synaptic plasticity.  Finally, Saito et al. examined the gene 
expression profile of the hippocampus of female Lewis rats fed a 12% alcohol solution as 
their only source of liquid for 15 months.  They identified 164 (out of 5000) differentially 
expressed genes between the alcohol fed and control rats.  Well represented functional 
categories included metabolism, signal transduction, cell surface antigens, protein 
synthesis and synaptic/neuronal developmental proteins (Saito et al., 2002). 
Microarray analysis has been used to survey alterations in brain gene expression 
of chronic alcoholics.  The regions of the frontal lobe (including the prefrontal and motor 
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cortices) are susceptible to physical damage following long-term alcohol consumption 
(Kril et al., 1997; Kril and Halliday, 1999) and are therefore often the focus of microarray 
studies in human alcoholics (Lewohl et al., 2000; Mayfield et al., 2002; Iwamoto et al., 
2004; Liu et al., 2004; Flatscher-Bader et al., 2005; Liu et al., 2006).  Several 
commonalities existed among the results of the microarray analyses comparing post-
mortem tissue of chronic alcoholics versus control subjects; including: 1) More genes 
were down-regulated than up-regulated in alcoholic versus control tissue (specifically, 
the frontal cortex) (Lewohl et al., 2000; Mayfield et al., 2002; Sokolov et al., 2003; Liu et 
al., 2004; Flatscher-Bader et al., 2005; Liu et al., 2006), 2) A large number of genes 
expressed in the alcoholic tissue were myelin-related (Lewohl et al., 2000; Mayfield et 
al., 2002; Iwamoto et al., 2004; Liu et al., 2004; Flatscher-Bader et al., 2005; Liu et al., 
2006) and 3) There were many overlapping functional groups represented in the 
differentially expressed genes:  signal transduction (Lewohl et al., 2000; Mayfield et al., 
2002; Sokolov et al., 2003; Iwamoto et al., 2004; Liu et al., 2004; Flatscher-Bader et al., 
2005), transcription/translation (Lewohl et al., 2000; Mayfield et al., 2002; Iwamoto et 
al., 2004; Flatscher-Bader et al., 2005; Liu et al., 2006), metabolism (Lewohl et al., 2000; 
Mayfield et al., 2002; Liu et al., 2004; Flatscher-Bader et al., 2005; Liu et al., 2006), cell 
cycle regulation and growth (Lewohl et al., 2000; Mayfield et al., 2002; Liu et al., 2004; 
Flatscher-Bader et al., 2005), cell adhesion (Lewohl et al., 2000; Mayfield et al., 2002; 
Sokolov et al., 2003; Iwamoto et al., 2004; Liu et al., 2004; Flatscher-Bader et al., 2005; 
Liu et al., 2006) and mitochondrial (Sokolov et al., 2003; Flatscher-Bader et al., 2005; 
Liu et al., 2006).  Two recently published studies have noted brain region- and treatment-
specific functional categories.  Flatscher-Bader et al. compared the gene expression 
profiles of the Nacc and the PFC of chronic alcoholics and found that only 6% of the 
alcohol-sensitive differentially expressed genes were common to both regions.  In 
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addition, the predominant functional groups assigned to the altered genes in each brain 
region were different from each other (Flatscher-Bader et al., 2005).  Liu et al. used 
Principal Components Analysis to separate controls and alcoholics in four different 
functional categories (Liu et al., 2006). 
In conclusion, alcohol affects the expression of a large number of genes 
simultaneously, often to only a small degree.  It is likely that these changes are not all 
direct effects of alcohol exposure, but also include secondary effects such as the 
downstream consequences of an altered transcription factor, membrane receptor, signal 
transduction cascade member or biochemical pathway member.  The types of functional 
categories represented by the alcohol-related genes are similar across animal models and 
alcohol paradigms indicating that alcohol affects a wide variety of cellular processes but 
in a consistent manner.  Finally, microarray analyses have contributed a great deal of 
knowledge about how alcohol affects central nervous system gene expression.  The next 
step is to examine the complex network of gene interactions and decipher how and why 
they may be contributing to the development of alcohol dependence. 
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Summary 
Alcohol dependence is a mental disease caused by a combination of 
environmental factors and genetic makeup.  The disease costs the United States billions 
of dollars annually and places a tremendous strain on society.  Several treatment options 
exist however none are universally effective—a phenomenon that is likely due to genetic 
makeup.  By understanding more about the genetic component of alcohol dependence, 
medication and treatment could be tailored to individuals or populations based on their 
genotype. 
Alcohol affects a wide range of receptors and neurochemical systems in the brain.  
The brain starts to adapt to these molecular and cellular alterations almost immediately.  
The current hypothesis is that over time, some of these changes become permanent.  
Stable changes in receptor amount, intracellular signaling, projections between brain 
regions and ultimately, basic brain function are thought to be caused in part by changes in 
gene expression.  Stable alterations in gene expression are thought to contribute to the 
manifestations of alcohol dependence, including tolerance, physical dependence 
(withdrawal) and the ultimate loss of control felt with regard to alcohol consumption. 
Both chronic (lifelong alcohol consumption) and acute (binge drinking) alcohol 
exposure alter brain gene expression and elicit signs of dependence.  Mice are a useful 
model with which to study the effects of chronic and acute alcohol exposure on brain 
gene expression given that 99% of the genes in the mouse genome have direct 
counterparts in humans.  In addition, almost all aspects of the disease have been modeled 
and studied successfully in mice using inbred strains, selected lines or genetically altered 
mice.  The B6 and D2 strains are easily obtainable, commonly used mice that differ 
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greatly in alcohol preference and withdrawal severity, making them ideal models with 
which to study the genetics of alcohol dependence. 
Several studies have used mouse and rat strains that diverge in alcohol-related 
behaviors to study the effects of alcohol administration on brain gene expression  
(Daniels and Buck, 2002; Saito et al., 2002; Treadwell and Singh, 2004; Kerns et al., 
2005).  While all of the aforementioned studies (and many others) have contributed to our 
knowledge of both predisposition and alcohol-related gene expression, the story is still 
incomplete.  Two key components are missing in all of the above studies—microarrays 
containing all of the clones representing the entire mouse transcriptome (the studies 
above used 7634, 24,000, 12,000 and 5000 clones on their microarrays, respectively) and 
a time course of gene expression changes following alcohol administration.  To truly 
discover the complete transcriptional response of the brain to alcohol, it is better to 
monitor expression changes over a time course following alcohol administration.  Gene 
expression is a dynamic process, with different genes having different half-lives and 
potentially regulating the transcription of other genes, therefore it is important to survey 
the alcohol-induced expression changes at multiple time points following alcohol 
exposure. 
In order to gain a better understanding of the complete transcriptional response of 
the mouse prefrontal cortex to acute alcohol exposure, the following four Specific Aims 
were proposed: 
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Specific Aims 
1)  To identify genetic and alcohol-related gene expression in C57BL/6J (B6) and 
DBA/2J (D2) whole brain using mRNA Differential Display (DD) 
 
2)  To generate additional targets for cDNA microarrays from genes identified in the DD 
screen 
 
3)  To identify genetic and alcohol-related temporally regulated gene expression in B6 
and D2 prefrontal cortex (PFC) using cDNA microarray analysis 
 Hypotheses to be tested: 
 - Acute alcohol exposure changes PFC gene expression temporally. 
- Acute alcohol exposure causes genotype-independent changes in PFC gene 
expression. 
 - Genetic differences in gene expression exist between B6 and D2 PFC. 
 
4)  To use computational tools to characterize differentially expressed genes identified in 
the cDNA microarray analysis 
 Hypotheses to be tested: 
- Co-expressed genes share common promoter region sequences. 
- Alcohol-related differentially expressed belong to different functional categories 
based on genotype and time post alcohol exposure 
- Genetic and alcohol-related differentially expressed genes can be categorized by 
specific neuronal cell type 
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CHAPTER 2:  MATERIALS AND METHODS 
Animals and animal husbandry 
MRNA DIFFERENTIAL DISPLAY 
Male C57BL/6J (B6) and DBA/2J (D2) mice, 60-90 days old, were group-housed 
under a 12 hour light/dark cycle with food and water available ad libitum.  All animal 
procedures were IACUC (Institutional Animal Care and Use Committee) approved 
according to NIH/AAALAC (National Institutes of Health/Association for Assessment 
and Accreditation of Laboratory Animal Care) guidelines. 
CDNA MICROARRAYS 
Male C57BL/6J (B6) and DBA/2J (D2) mice, 70-100 days old, were group-
housed under a 12 hour light/dark cycle with food and water available ad libitum.  All 
animal procedures were IACUC approved according to NIH/AAALAC guidelines. 
Experimental design and tissue collection 
MRNA DIFFERENTIAL DISPLAY 
B6 and D2 mice (n = 2 per strain) were injected intraperitoneally (i.p.) with an 
acute dose of 4 g/kg ethanol (200 proof, diluted to 20% v/v in 0.9% sodium chloride) or 
an equivalent volume of saline (0.9% sodium chloride).  Animals were sacrificed by 
cervical dislocation and whole brains removed at 2 hours and 6 hours post-injection, 
immediately frozen in liquid nitrogen and stored at -70ºC. 
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CDNA MICROARRAYS 
B6 and D2 mice were habituated to injection for at least three days with a 0.5 ml 
intraperitoneal (i.p.) injection of saline (0.9% sodium chloride).  On the day of the 
experiment, the mice were injected in random order with 4 g/kg, i.p. ethanol (200 proof, 
diluted to 20% v/v in 0.9% sodium chloride) or an equivalent volume of saline.  Alcohol-
injected mice were sacrificed by cervical dislocation at 2, 7, 12 and 24 hours post-
injection (n = 7 per group) while saline control mice were sacrificed at 2 hours post-
injection (n = 7 per group).  Seven brain regions, including the prefrontal cortex, were 
dissected from whole brain and immediately frozen in liquid nitrogen within two minutes 
of sacrifice and three minutes of removal from home cage.  Prefrontal cortex was isolated 
by making an incision along the fissura longitudinalis cerebri, peeling the cortex flat and 
dissecting the anterior portion of the brain back 1.7 mm posterior, approximately 1.5 mm 
rostral to bregma, including portions of the following anatomical regions:  agranular, 
cingular, frontal association, motor, orbital, pre- and infralimbic cortex (Franklin and 
Paxinos, 1997).  See Figures 2.1 and 2.2 for more detail.  Samples were stored at -70ºC.   
Figure 2.1:  Dorsal view of mouse brain.  The cortex was dissected along the fissura 
longitudinalis cerebri from #3 (red) to #3 (blue) such that the left and right cortical 
hemispheres could be splayed flatly to either side of the brain.  An anterior section of the 
brain, from #3.2 (red) to #1.5 (red), was dissected out as the prefrontal cortex.  The zero 
coordinate is the bregma point, with the red numbers running anterior/rostral to bregma 
and the blue numbers running posterior/caudal to bregma.  The lines/numbers are spaced 
1 mm apart. 
 
 
(http://www.mbl.org) 
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Figure 2.2:  Schematic showing prefrontal cortex dissection.  A dorsal view of the 
mouse brain, with the left and right cortical hemispheres splayed flatly to either side of 
the brain. The yellow color indicates the regions that were dissected out as the prefrontal 
cortex. 
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RNA isolation and quantification 
MRNA DIFFERENTIAL DISPLAY 
Total RNA was isolated from whole brain using RNA STAT-60 (Tel-Test, Inc., 
Friendswood, TX) according to the manufacturer’s protocol.  Individual brains were 
homogenized in 6 ml of RNA STAT-60 using a Polytron homogenizer (Kinematica, 
Lucerne, Switzerland).  RNA was resuspended in DEPC-treated water and quantified 
with the DU640 UV/Vis spectrophotometer (Beckman Coulter, Inc., Fullerton, CA).  
Samples were DNase treated with 1 U DNase I/μg RNA (Gibco-BRL) for 15 minutes at 
37ºC, re-extracted with acid-phenol/chloroform, resuspended in DEPC-treated water and 
quantified using the spectrophotometer.  Samples were stored at -70ºC.   
CDNA MICROARRAYS 
Total RNA was isolated from prefrontal cortex using RNA STAT-60 (Tel-Test, 
Inc., Friendswood, TX) according to the manufacturer’s protocol.  Individual prefrontal 
cortices were homogenized in 1 ml of RNA STAT-60 using a Polytron homogenizer 
(Kinematica, Lucerne, Switzerland).  RNA was resuspended in 15 μl of nuclease-free 
water (Ambion, Austin, TX) and quantified with a NanoDrop ND-1000 UV/Vis 
spectrophotometer (NanoDrop Technologies, Wilmington, DE).  The average 260/280 
ratio was 1.86 and the average 260/230 ratio was 2.06; indicating that the small tissue 
mass and low resuspension volume did not negatively affect the RNA quality.   In 
addition, the RNA was checked for degradation using an Agilent 2100 Bioanalyzer 
(Agilent Technologies, Palo Alto, CA).  See Figures 2.3 and 2.4 for more detail.  Samples 
were stored at -70ºC. 
Figure 2.3:  Quality determination of total RNA isolated from prefrontal cortices.  A 
pseudo-gel created from the Agilent 2100 Bioanalyzer of ten prefrontal cortex total RNA 
samples.  The two bands in each sample represent 18S and 28S rRNA.  The ladder is the 
RNA 6000 ladder from Ambion (Austin, TX).  The bands are sharp and distinct with no 
signs of RNA degradation. 
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Figure 2.4:  Electropherograms of two prefrontal cortex total RNA samples.  The top 
(sample B6 2-5) and bottom (sample D2 4-4) electropherograms represent two single 
wells from the pseudo-gel in Figure 2.3.  The two tall peaks in the electropherograms 
represent the 18S and 28S rRNA bands, respectively.  A relatively flat, consistent 
baseline reading indicates no degradation is present. 
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mRNA Differential Display (DD) 
REVERSE TRANSCRIPTION 
5 μg of total RNA was reverse transcribed using SuperscriptTM II RNase H- 
reverse transcriptase (Invitrogen, Carlsbad, CA) according to the manufacturer’s 
protocol, with the following modifications:  1) A one-base anchored oligo dT primer, H-
T11M (GenHunter, Brookline, MA; H = HindIII restriction sequence, M = A, G or C) 
replaced the oligo (dT)12-18 primer, thereby creating three different cDNAs from every 
sample of RNA, (2) An initial denaturation incubation at 75ºC for 10 minutes followed by 
icing was performed,  (3) The final dNTP concentration was increased to 0.5 mM from 
25 μM as this gave substantially better DD banding results,  (4) The 5X 1st strand buffer, 
DTT (dithiothreitol) and dNTPs were added in a single pipetting from a master mix in 
order to minimize pipetting errors and (5) A 2 minute incubation at 42ºC allowed good 
annealing of primer, as did pre-warming of tubes prior to the addition of enzyme.  
Incubation at 42ºC proceeds for an additional 50 minutes and is followed by thermal 
termination of enzyme activity at 75ºC for 15 minutes.  Synthesized cDNA was 
resuspended in 260 μl DEPC-treated water and stored at -20ºC. 
POLYMERASE CHAIN REACTION (PCR) AMPLIFICATION 
Each of the three types of cDNAs created in the reverse transcription (using A, G, 
or C anchored primers) was PCR amplified using each of the 80 arbitrary forward 
primers (H-AP; AP = 13mer of arbitrary sequence) and one of the three reverse primers, 
H-T11M (M = A, G or C, depending on the cDNA being amplified) in the RNAimageTM 
kit (GenHunter) for a total of 240 PCR reactions per original sample of RNA.  Reactions 
were performed as described in Liang and Pardee (Liang and Pardee, 1998) with the 
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following exceptions:  1) α-[33P-dATP] (>2000Ci/mmol) replaced α-[35S-dATP] (Callard 
et al., 1994),  2) Denaturation temperature was increased, 3) Annealing temperatures 
were adjusted based on the sequence of the forward primer to enhance specificity of the 
reaction and 4) Extension time was increased.  Together these changes seem to have lead 
to a reduction in false positives and larger sized fragments displayed.  Samples are run 
using Robbins Scientific (Sunnyvale, CA) cycle plates having 192 split wells which were 
verified to work well (Chen et al., 1994).  The PCR conditions for thermocycler runs 
(GeneAmp PCR System 9600, Perkin Elmer Cetus) were optimized to include a 2 minute 
“hot start” at 96ºC to ensure maximal denaturation.  PCR cycles were:  40 cycles of 
denaturation at 96ºC for 30 seconds, annealing at 35-48ºC for 1 minute (based on optimal 
binding for each primer, determined using PC-based program Oligo, Oxford Molecular), 
and extension at 72ºC for 1 minute.  A final 7 minute extension at 72ºC followed by an 
indefinite 4ºC incubation until removal of the samples completes the PCR.  PCR products 
were heat denatured for 2 minutes at 96ºC, placed on ice and loaded on a 6% 
polyacrylamide/urea sequencing gel (SequaGel-6, National Diagnostics, Atlanta, GA).  
Samples were not loaded on the gel until the gel reached 50ºC.  The gels were run at 55-
60ºC with the voltage prevented from rising above 1700.  Wattage was usually 85, 
considerably higher than recommended.  The gel was transferred to 3M filter paper, dried 
and exposed to X-ray film (Kodak, Rochester, NY) overnight.  Film was developed using 
a Kodak X-OMAT 2000A processor machine.  Autoradiograms of the gels were 
examined for genes that were differentially expressed between control mice, as a result of 
alcohol exposure or both (based on intensity and/or presence of bands).  See Figure 2.5 
for an example of what a differential display gel looks like. 
Figure 2.5:  Example of a differentially expressed gene on a differential display gel.   
The banding pattern difference between the B6 and D2 samples indicates this gene is 
expressed at a higher level in the B6 mouse than the D2 mouse, and is therefore 
genetically divergent. 
 
 
 58
 59
 
CLONING 
Bands of interest were outlined on the backside of the autoradiogram with a fine 
pointed woman’s eyeliner (Max Factor).  The autoradiogram was then easily aligned to 
the blotted gel using several unique spots of sample containing radioactivity and dye (that 
were spotted prior to film exposure).  The autoradiogram was pressed down on the dried 
gel to transfer the eyeliner outline to the gel to demarcate where the band was on the 
dried gel.  The band was excised from the dried gel using a clean razor blade.  The band 
was soaked in 30-50 μl of filtered water for 10 minutes, boiled for 15 minutes and spun 
down.  The DNA in the band’s “supernatant” was ethanol precipitated and resuspended in 
10 μl of filtered water.  The DNA was PCR amplified using the same forward and reverse 
primers, temperatures and cycle lengths as in the differential display (DD) PCR reaction.  
The PCR product was run on a 1% agarose gel, the band excised with a clean razor blade 
and the DNA extracted using the freeze-squeeze method (Islam et al., 2002).  In this 
method, the agarose is subjected to multiple freeze-thaw cycles, placed inside a piece of 
parafilm and squeezed.  The supernatant was ethanol precipitated and resuspended in 5 μl 
of filtered water.   
The PCR product was subcloned into a T/A cloning vector (pGEM®-T Easy 
Vector, Promega, Madison, WI) (see Figure 2.6) according to the manufacturer’s 
protocol, except that the volumes of all of the reagents were cut in half.  1 μl of ligation 
reaction was added to 50 μl of electrocompetent cells (XL1-Blue, Stratagene, La Jolla, 
CA), which were transformed using a GenePulser II System (Biorad, Hercules, CA) 
according to the manufacturer’s protocol.  Electroporated cells were gently shaken at 
37ºC for 30 minutes to 1 hour in 1 ml of SOC medium, spun down, resuspended in a 
small volume of SOC and spread on agar plates (containing X-gal/IPTG/ampicillin) 
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which were incubated overnight (inverted) at 37ºC.  Positively transformed colonies were 
chosen based on blue/white color screening and the Wizard® Plus SV Minipreps DNA 
Purification System (Promega) was used to isolate the DNA.  A sample of the DNA was 
cut with 50 U/μl of EcoRI to ensure presence of the insert. 
Figure 2.6:  pGEM-T Easy Vector.  The PCR products generated by the differential 
display screen were subcloned into the multiple cloning site of the vector. 
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CLONE IDENTIFICATION 
Clones were sequenced with an automated DNA sequencer (ABI 373A, using Taq 
dye terminator chemistry; VAMC Molecular Biology Core Facility, Portland, OR), using 
the T7 primer.  Sequences were entered into Omiga 2.0 (Genetics Computer Group, 
Madison, WI) and aligned with the T7 and SP6 primer sequences so that the primer 
sequences could be deleted from the clone sequence.  Truncated clone sequences were 
entered into the Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990) and 
based on their E score, identified as known genes, expressed sequence tags (ESTs) or 
unknown genes. 
cDNA microarrays 
MICROARRAY FABRICATION 
Clone preparation 
Clones printed on the University of Texas at Austin custom cDNA microarrays 
included the NIH BMAP UniGene library (~11,000 clones), Sequence Verified IMAGE 
clones (~5000) (ResGen/Invitrogen, (Carlsbad, CA), The National Institute of Aging 
clone set (~22,000 clones) and the clones (~300) generated from the mRNA differential 
display screen.  Based on assignment to Unigene clusters, approximately 25,000 distinct 
genes are represented in the first three clone sets.  The differential display clones 
represent an additional 150 unique genes or ESTs. 
The three purchased clone sets were shipped as frozen glycerol stocks of E. coli.  
A small portion of each frozen clone was distributed into individual wells of 96 well 
plates so each could be amplified by PCR.  PCR amplification was performed in a 
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Perkin-Elmer 9600 thermocycler using commercially available primers (primer pairs 
were chosen based on the vectors used in each clone set) in 50 μl reactions containing 
PCR buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 10 pmol of each primer, 5 U Taq 
polymerase, and 0.5 μl of the bacterial culture.  PCR cycles included annealing at 55ºC 
for 20 seconds and extension at 72ºC for 90 seconds for a total of 30 cycles.  5 μl of each 
reaction was then analyzed on a 1% agarose gel to verify the success of the PCR. 
Primers were designed (TAEasy5’ and TAEasy3’) to PCR amplify the clones 
generated by the mRNA differential display.  DD clones were amplified in 100 μl 
reactions using standard concentrations of MgCl2, dNTPs, primers, MasterAmpTM Tfl 
DNA polymerase and MasterAmpTM Tfl 20X PCR buffer (EPICENTRE Biotechnologies, 
Madison, WI).  The PCR conditions were as follows:  (1) A 2 minute “hot start” at 94ºC, 
(2) 40 cycles of 94ºC for 30 seconds, 62ºC for 30 seconds, 72ºC for 60 seconds, (3) A 7 
minute extension at 72ºC and (4) An indefinite hold at 4ºC.  The amplification was 
performed on a PTC-100 PCR machine (MJ Research, Inc. (Biorad), Waltham, MA).  A 
small portion of the PCR product was analyzed on a 1% agarose gel to ensure the 
presence of a single band (Figure 3.3).  For each unique gene or EST found to be 
differentially expressed in the DD screen, two clones representing the same DNA 
sequence were chosen to add as targets to the microarray.   The PCR products of these 
clones were transferred to U bottom plates and precipitated.  All clones (purchased and 
DD) were precipitated in the same manner, using isopropanol and sodium acetate.  The 
precipitated clones were resuspended in water, transferred to 384 well plates (Genetix 
USA Inc., Boston, MA), spun down in an Eppendorf 5810R centrifuge (Westbury, NY), 
dried down in a Savant Speedvac® Plus SC210A (ThermoQuest (Thermo Electron 
Corporation), Waltham, MA) and stored at room temperature.  Several copies of each 384 
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well plate were created for longevity of the clones.  Prior to a print, the DNA in one set of 
384 well plates was resuspended in 6 μl of 3X saline-sodium citrate (SSC) buffer. 
Printing the microarrays 
Glass slides (Gold Seal, Erie Scientific Co., Portsmouth, NH) were cleaned for 
two hours in a solution of 2.5 N NaOH in 60% ethanol, followed by a water rinse.  Slides 
were soaked for 30 minutes in a solution of 0.017% w/v poly-L-lysine (Sigma-Aldrich 
Corp., St. Louis, MO) in 0.1X phosphate buffered saline (PBS), rinsed with water, and 
spun dry at 600 rpm in a GH3.8 rotor in an Allegra 6R centrifuge (Beckman Coulter Inc., 
Fullerton, CA) for 10 minutes.  Slides were stored in a cool, dry place for a minimum of 
10 days before printing. 
All clones were stored in 384 well plates as dried pellets.  Prior to each print, 
clones were resuspended in 6 μl of water or 3X SSC.  Resuspension was performed using 
a Biomek FX Laboratory Automation Workstation (Beckman Coulter, Inc., Fullerton, 
CA) one day prior to printing.  The 384 well plates were covered with tape to form an air-
tight seal and stored at 40C overnight.  The next day the plates were loaded consecutively 
on the custom built arraying robot.  The arraying robot used to print the arrays was built 
by and is housed in the Iyer lab on the UT campus.  It is similar to that of  (DeRisi et al., 
1997).  The proper alignment, calibration and movement of the robot were controlled by 
the ArrayMaker software (http://derisilab.ucsf.edu/arraymaker.shtml). The 48 stainless 
steel printing tips (MicroQuill® 3000 Array Pin, Majer Precision Engineering, Tempe, 
AZ) were individually checked for sharpness under a magnifying glass prior to printing.  
260 poly-L-lysine coated slides were taped down on the arrayer platform, the first plate 
of cDNA clones was placed on the arrayer and the print started.  The print head 
containing the steel printing tips descended eight times into each 384 well plate, captured 
picoliter amounts of cDNA and printed the cDNA on each slide.  Plates were changed 
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every 20 minutes for approximately 36 hours until all 39,000 cDNA clones were printed 
on each of the 260 glass slides.  Slides were removed from the arrayer platform and 
stored in slide boxes in a cool dry area. 
MICROARRAY HYBRIDIZATION 
Post processing the microarrays 
Slides were hydrated by holding them one at a time, array side up, above a 90ºC 
water bath for 10 seconds.  The steam from the water bath hydrates each spot of dried 
cDNA to allow it to expand and form a uniform circle on the slide.  Slides were dried by 
gently waving them in the air for 10 seconds.  Printed cDNA was crosslinked to the slide 
in a UV Stratalinker 1800 (Stratagene, La Jolla, CA) for 1.5 minutes.  The UV light 
creates a covalent bond between the positively charged NH2 group on the poly-L-lysine 
and the negatively charged phosphate backbone of the cDNA.  The slides were 
transferred to a slide rack, immersed in isopropanol and gently shaken for 15 minutes.  
Afterwards, the slide rack was transferred to a boiling water bath for 10 minutes to 
denature the cDNA.  Excess water was removed from the slides and slide rack before the 
rack was placed in a GH3.8 rotor in the Allegra 6R centrifuge and spun dry at 800 rpm 
for 10 minutes.  Slides were hybridized within two days of post-processing. 
cDNA labeling and hybridization 
cDNA was synthesized and dye-labeled from total RNA using the 3DNA Array 
900 kit (Genisphere, Hatfield, PA).  The 3DNA technology uses an end-labeling 
technique to attach fluorescent dyes to the cDNA.  The benefits of this technology over 
more traditional labeling methods are outlined in Figure 2.7.   
The 3DNA Array 900 kit protocol is described here briefly.  500 ng of total RNA 
from the alcohol-treated or saline control mouse or 1 μg of total RNA from the B6 
 66
reference pool (whole brain RNA isolated from 100 male B6 mice) was added to 1 pmole 
of Cyanine-3- (Cy-3-) or Cyanine-5- (Cy-5-) -specific RT primer (respectively) and 
nuclease free water to a final volume of 6 μl.  The Cyanine dyes are bright, intense dyes 
that have sharp, distinct absorption and emission spectra, allowing good spectral 
separation when used in co-labeling experiments (Amersham Pharmacia Biotech 
bulletin).  The RNA-primer mix was heated to 80ºC for 5 minutes, then immediately 
transferred to ice.  RNA was reverse transcribed for 2 hours at 42ºC in a reaction 
containing 5X SuperScriptTM II First Strand Buffer and SuperScriptTM II RNase H- 
reverse transcriptase (Invitrogen, Carlsbad, CA), 0.1 M DTT, Superase-in RNAse 
Inhibitor, and dNTP mix.  The reverse transcription was stopped with 1 μl of 1 M 
NaOH/100 mM EDTA, incubated at 65ºC for 10 minutes, and neutralized with 1.2 μl of 2 
M Tris-HCl, pH 7.5. 
Figure 2.7:  A comparison of methods for labeling cDNA with fluorescent dyes:  the 
amino-allyl indirect labeling method versus the Genisphere 3DNA end-labeling 
technology.  The Genisphere technology is advantageous over the more traditional 
indirect labeling method for several reasons (outlined below). 
 
1) Amino-allyl indirect labeling method:  In this method, amino-allyl dNTPs (AA-dUTP) 
are incorporated during cDNA synthesis, followed by the chemical coupling of amine 
reactive dyes (Cy-3 or Cy-5) (see below).  As a result, the fluorescent signal is dependent 
on the base composition and length of the cDNA.  In addition, each cDNA molecule may 
contain only 2-50 fluors, requiring that a large amount (15 μg) of RNA be labeled in 
order to detect a signal.  Finally, dye spacing may negatively affect hybridization 
efficiency. 
 
 
 
2)  Genisphere 3DNA end-labeling technology:  In this method, each RNA sample is 
reverse transcribed using an oligo dT primer with a unique capture sequence attached to 
its 5’ end. 
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(http://www.genisphere.com) 
 
The capture sequence is complementary to one of two fluorescently labeled dendrimers.  
The dendrimers are 3-dimensional structures composed of multiple layers of DNA 
monomers.  Each monomer is composed of two DNA strands that are complementary to 
each other in the center portion of the strands.  Each dendrimer has 850 (Array 900 kit) 
fluorescent dyes (Cy-3 or Cy-5) attached to it.  Such a large amount of fluorescent dye 
associated with each molecule of cDNA allows a small amount of RNA to be labeled 
(500 ng).   
 
 
(http://www.genisphere.com) 
 
The cDNA containing the capture sequence is hybridized first to the microarray slide, 
followed by the dendrimers containing the fluorescently labeled dyes.  Therefore, each 
cDNA is represented by only one dendrimer, producing a base-composition- and length-
independent signal. 
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cDNA from an alcohol-treated or saline control animal was always hybridized 
against cDNA from a reference.  In the Genisphere protocol, the cDNA is hybridized to 
the array slide first, followed by the fluorescent dyes.  This two-step hybridization 
process is described here.    Each experimental cDNA (alcohol treated or saline control) 
was combined with B6 reference cDNA and added to 2X Hybridization Buffer, LNA dT 
Blocker, 1 μl of 100 ng/μl COT-1 DNA and nuclease free water, to a total volume of 65 
μl.  This mix was incubated for 10 minutes at 80ºC, then at 65ºC until it was applied to 
the microarray slide.  Each microarray slide was pre-warmed to 65ºC before the cDNA 
mix was added to it.  The cDNA mix was pipetted onto the microarray and a microscope 
coverslip was gently place on top of the mix.  The slide was then inserted into a 
humidified hybridization chamber (Genetix Limited, United Kingdom), which remained 
on the 65ºC heat block while the other slides were prepared (Figure 2.8).  As many as 10 
slides can fit into each Genetix chamber at one time and no more than two chambers were 
used simultaneously in an experiment.  The Genetix chamber(s) were submerged in a 
63ºC water bath overnight.  The next day, each slide was removed one at a time and 
placed in a slide rack submerged in a 65ºC, 2X SSC, 0.2% SDS wash solution.  Once all 
the slides were immersed in this solution, they were shaken for 15 minutes at 65ºC.  Two 
more 15 minute room temperature washes followed, in 2X SSC and 0.2X SSC, 
respectively.  The slide rack was removed from the final wash solution and spun in an 
Allegra 6R centrifuge for 10 minutes at 800 rpm to dry.  All of the following steps were 
performed in the dark.  A 3DNA hybridization mix was made that contained a Cy-3 and a 
Cy-5 3DNA Array 900 Capture Reagent, 2X Hybridization Buffer, 1 μl of 100 ng/μl 
COT-1 DNA and nuclease free water, to a total volume of 65 μl.  This mix was incubated 
for 10 minutes at 80ºC, then at 65ºC until it was applied to the microarray slide.  The 
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same technique was used to apply this mix to the slides as was used in the cDNA 
hybridization.  The slides were incubated for 4-5 hours in a 63ºC water bath.  The slides 
were removed from the Genetix chamber(s), washed, and spun dry using the same 
techniques listed above.  Once all the slides were dry, they were stored under argon gas 
during scanning to prevent oxidation of the Cy-5 dye by ozone in the air. 
Figure 2.8:  cDNA hybridization step of microarray process.  Each microarray slide 
was pre-warmed to 65ºC before the cDNA mix was added to it.  The cDNA mix was 
pipetted onto the microarray and a microscope coverslip was gently place on top of the 
mix.  The slide was then inserted into a humidified hybridization chamber (Genetix 
Limited, United Kingdom), which remained on the 65ºC heat block while the other slides 
were prepared.  As many as 10 slides can fit into each Genetix chamber at one time and 
no more than two chambers were used simultaneously in an experiment.  Performing 20 
array hybridizations simultaneously decreases technical variability among the arrays. 
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 The combination of the Genisphere 3DNA technology, high-throughput 
hybridization techniques and minor changes to many other aspects of the microarray 
protocol resulted in high quality microarrays—with little background and strong signal 
intensity (Figure 2.9). 
Figure 2.9:  Reproducibility of microarrays using Genisphere 3DNA Array 900 kit.   
A single block (#31) is shown from four different microarray hybridizations representing 
4 n mice.  cDNA synthesized from 500 ng of total RNA (labeled with Cy-3) from the 
prefrontal cortex of a D2 mouse sacrificed 12 hour post alcohol injection was hybridized 
against 1 μg of B6 reference RNA (labeled with Cy-5).  The same spot color and 
intensity is seen in all four blocks. 
 
Array / mouse number:  D2 3-4 Array / mouse number:  D2 4-4
Array / mouse number:  D2 6-4Array / mouse number:  D2 5-4
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Array scanning and gridding 
Slides were scanned using a GenePix 4000A or B scanner (Axon Instruments, 
Inc., Union City, CA).  The scanner has two lasers, 532 nm and 635 nm, that excite Cy-3 
(green) and Cy-5 (red) respectively.  The emission filters are 575DF35 (green; ~557-592 
nm) and 670DF40 (red; ~650-690 nm).  Two photomultiplier tubes (PMTs) inside the 
scanner detect the fluorescent light emitted from the dyes.  The sensitivity of the PMTs 
can be adjusted by increasing or decreasing the PMT gain (voltage).  The PMT gain for 
each laser was adjusted during scanning to achieve an intensity ratio of 1.00.  The 
intensity ratio is the total number of intensity quanta (counts) on the array from the red 
channel over the total number of intensity quanta from the green channel.  An intensity 
ratio of 1.00 ensures that the intensities from both lasers are balanced, that the red and 
green traces in the intensity histogram overlap and that the full range of intensities (1-
65,535) are utilized. 
The array spots were labeled and quantified using SpotReader (Niles Scientific, 
Portola Valley, CA) and/or GenePix Pro 5.1 (Axon Instruments, Inc., Union City, CA).  
To label and quantify the spots, a grid of open circles was placed on top of the scanned 
array image (Figure 2.10).  The grid contained clone identification information for each 
spot.  The size and shape of the open circles was manually adjusted to encompass each 
spot on the array.  A spot was flagged (excluded from further analysis) if it ran together 
with another spot, was incomplete, was non-existent due to poly-L-lysine peeling or had 
false color (where the signal was not from a true hybridization).  As few spots as possible 
were flagged. 
After gridding is complete, a GenePix Results (GPR) file is created that contains 
clone identification and red/green intensity information for every spot on the array. 
Figure 2.10:  Example of a grid placed over a scanned microarray slide to label and 
quantify the spots.  A snapshot of spots from slide #85, sample B6 8-3 (seven hours post 
alcohol exposure).  The size of the white circles surrounding the spots is manually 
adjusted to encompass each spot.  All of the spots in this picture have similar color 
distribution within the spot and are not compromised in any way (necessitating a “flag”). 
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ARRAY ANALYSIS 
Normalization, standardization and filtering 
One assumption common to all microarray experiments is that the expression 
levels of most of the genes in the two samples hybridized against each other are equal, 
thereby producing an array with mostly yellow spots (it is important to note that this 
assumption only holds true for microarrays that contain a large number of random 
cDNAs—not arrays that contain a custom set of genes known to be differentially 
expressed in the hybridized samples).  Based on this assumption, several steps are taken 
to balance the signal contribution and intensity of the red and green channels on every 
array so that all arrays in an experiment can be directly compared to each other.  The first 
step is during scanning when the gain of the PMTs is adjusted to produce an array with 
equal signal contribution from the Cy-3 and Cy-5 dyes.  In reality, it is difficult to 
produce an intensity ratio of 1.00 (representative of equal signal contribution), with ratios 
usually ranging from 0.85 to 1.15.  However this minor imbalance can be corrected by 
the second step, normalization. 
Normalization is a mathematical process used to remove systematic variation 
from array experiments; meaning, variation that arises from the technology rather than 
from biological differences between the RNA samples (Smyth and Speed, 2003).  
Examples of such systematic variation are differences in labeling efficiency between the 
two fluorescent dyes, physical properties of the dyes (heat, light and ozone sensitivity, 
relative half-life) and scanner settings (Yang et al., 2002; Fare et al., 2003).  A common 
method of normalization is to apply a normalization factor to the red or green (or both) 
intensity of every gene on the array, such that the average ratio of every gene on the array 
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becomes 1 (Quackenbush, 2002).  Again, this method relies on the assumption that most 
genes do not respond to experimental conditions.  A different normalization factor is 
applied to each array but the end result is the same, allowing all arrays in an experiment 
to be directly comparable.  However this global, linear method of normalization does not 
take into account intensity- or spatially-dependent dye biases, two commonly occurring 
sources of systematic variation on arrays (Yang et al., 2002).  For example, print tips can 
produce spots of varying sizes between blocks on the array (a single print tip produces all 
the spots in a single block), the amount of cDNA printed on the slides can vary 
depending on the slide’s position on the arrayer and the hybridization of the dyes can be 
non-uniform across the array.  All of these factors can negatively affect the calculation 
and application of the global normalization factor to all the genes on the array.  A within-
print tip, intensity-dependent method of normalization was developed to account for these 
issues.  First, the intensities and intensity ratios of every gene in a single block on the 
array are plotted against each other to reveal intensity-specific artifacts in the ratios.  
Second, these artifacts are corrected by the application of a locally weighted linear 
regression (lowess), resulting in an intensity-specific normalization of all the genes in a 
single block on the array (Quackenbush, 2002; Smyth and Speed, 2003). 
Microarrays were normalized within the R environment (Ihaka and Gentleman, 
1996) using the Statistics for Microarray Analysis (SMA) add-on package (Yang et al., 
2002).  Specifically, the within-print tip non-linear lowess normalization function in 
SMA was used for normalization (Figure 2.11).   A program developed in our lab that 
automates the normalization procedure was used to apply the normalized values to the 
GPR files. 
Figure 2.11:  Histogram of two microarrays before and after normalization.  The net 
(background-subtracted) intensity distribution of the red and green channels on each 
array was plotted on a histogram prior to and after array normalization to ensure the 
normalization process produced normally distributed net intensities.  On the x-axis is the 
range of intensity values possible for any given spot on the array (1-65,535 (log2 
transformed)).  On the y-axis is the frequency of each intensity value. 
 
1)  Mouse/array number:  B6 6-5 (pre-normalization) 
 
 
2)  Mouse/array number:  B6 6-5 (post-normalization) 
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3)  Mouse/array number:  D2 3-1 (pre-normalization) 
 
 
 
4)  Mouse/array number:  D2 3-1 (post-normalization) 
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The normalized GPR files were uploaded and stored in the Longhorn Array 
Database (LAD) (Killion et al., 2003).  Information such as gene identifiers (name, clone 
ID, accession number, chromosome number), intensity values and log2 ratios can be 
retrieved from the LAD for a single array or a pre-defined group of arrays.  Microarray 
data was retrieved from the LAD as net (background-subtracted) median intensity values.  
The Channel 1 (Ch1 (alcohol-treated or control Cy-3 labeled sample)) and Channel 2 
(Ch2 (reference Cy-5 labeled sample)) intensities of every gene (39,335) on all 70 arrays 
were downloaded as two separate text files.  Obtaining Ch1 and Ch2 intensity values for 
each gene (as opposed to the more traditional log2 ratio values) has several benefits, 
including:  1) Genes that are turned on or off as a result of alcohol exposure are 
maintained and 2) Intensity information is maintained.  Genes that go from “on” to “off” 
or vice versa can have very low intensity values, which when converted to log2 ratios can 
produce artificially high, low or undefined values depending on whether the intensity 
value was in the numerator or denominator.  Artificially high or low values may skew the 
data and undefined values would be removed from further analysis.  This problem can be 
avoided by keeping gene values in the intensity format.     
The two text files were converted to log2 scale so that the following equation 
could be applied (on a per gene basis) to standardize all arrays to each other: 
Ch1adj = Ch1 + (Ch2med – Ch2) 
Ch1adj is the adjusted Ch1 log2 intensity for each spot, Ch1 is the original Ch1 log2 
intensity for that spot, Ch2med is the median log2 Ch2 intensity of all of the spots for that 
gene, and Ch2 is the individual log2 Ch2 intensity of each of the spots for that gene.  
Since all of the microarrays were hybridized with the same sample in Ch2, the Ch1 
intensities can be directly compared when adjusted proportionally with the median (or 
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average) Ch2 intensity across all arrays being compared. This technique allows the 
microarrays to be analyzed without the use of ratios, and allows for the comparison of 
any condition to any other condition and across experiments as long as the same 
reference sample was used on all of the arrays. The output of the standardization 
procedure is a single file with adjusted Ch1 intensities for all of the microarrays 
originally downloaded.   
A conservative selection of filters was applied to the genes downloaded from the 
LAD in order to maintain as many genes for statistical analysis as possible, while not 
compromising gene reliability.  A text file with the adjusted Ch1 intensity values for 
39,335 genes on 70 arrays was opened in Excel (Microsoft, Redmond, WA) for filtering.  
An outlier test was run in Excel on each group of 7 n arrays (10 groups total) to remove 
values that were greater than or less than +/- two times the standard deviation of the 
mean.  Blank cells replaced outlier values in Excel.  Genes were selected for further 
analysis if they had at least 6 out of 7 n values present.  After this filter, 36,694 genes 
remained.  Finally, an intensity filter was applied to maintain only those genes with at 
least one group of 6-7 n having an average net normalized and standardized intensity of 
25 or greater, leaving 26,418 genes for statistical analysis. 
Statistics 
One of the major advantages of performing microarray experiments is that 
thousands of gene expression differences can be detected simultaneously.  The goal is to 
identify which of those thousands of gene expression differences are truly “significant.”  
Until a few years ago, it was common practice to identify significant genes by their fold 
change values.  For example, any gene that had a two-fold increase or decrease in 
expression from control was deemed a significantly differentially expressed gene.  
Although this method of detection did produce gene lists that are often validated by more 
 82
stringent criteria today, it did not take into account the variance in the system.  In 
addition, it failed to account for those genes with a less than two-fold change in 
expression that may have also contributed to the phenotype of interest.  To solve this 
problem, statistical methods started to be incorporated into microarray analysis. A 
common statistical test used to identify differentially expressed genes between conditions 
A and B is the Student’s t-test (developed by W.S. Gossett).  The output of a t-test is a 
probability (p) value describing the difference between conditions A and B, while taking 
into account the variance in the samples representing each condition.  As the number of 
samples representing an experimental condition increases, so does the accuracy of the 
estimate of experimental variance.  For any given gene on a microarray, the higher the 
ratio of the expression difference between samples to the variance within samples, the 
lower the p-value describing the two experimental conditions being compared (and the 
more likely the detected gene expression difference is real).  The samples themselves can 
be either technical replicates (running the same sample from a single organism on 
multiple arrays), biological replicates (running multiple samples from multiple organisms 
on multiple arrays) or a combination of both (Pavlidis, 2003).  Technical replicates are 
often used for quality control purposes only, as they cannot accurately represent an 
experimental condition as biological replicates can.  Ideally, a large number of biological 
replicates would be used to represent each experimental condition being compared in a 
microarray study.  However, due to issues such as the cost of the arrays and/or limited 
sample availability, such a large sample size is not feasible.  The general consensus is 
that a minimum of five biological replicates is necessary to identify differential gene 
expression using microarrays (Reimers, 2005).  
With any method of statistics applied to a set of scientific data, the goal is always 
to find the appropriate balance of Type I and Type II errors.  In a Type I error, the null 
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hypothesis is rejected when it should not be, generating false positives.  In a Type II 
error, the null hypothesis is not rejected when it should be, generating false negatives 
(Zar, 1999).  In trying to balance the generation of false positives and false negatives, 
scientists often settle on a false positive rate of 5% (p-value of 0.05), meaning that 5% of 
the time, the null hypothesis will be rejected erroneously.  Although controlling both 
types of errors is important in microarray data, one could argue that the generation of 
false positives may be more detrimental considering microarrays are often used as 
hypothesis-generating techniques and therefore, it is often the case that genes identified 
as differentially regulated by microarrays are further characterized in the system of 
interest.  Therefore, pursuing a gene that is not actually differentially regulated (a false 
positive) may lead to wasted time and money.  With regard to experiments that test only 
one hypothesis at a time, a false positive rate of 5% is usually acceptable.  However with 
microarray experiments, thousands of hypotheses are being tested simultaneously.  
Therefore, a p-value of 0.05 generates a large number of false positives (with 40,000 
genes, 2000 false positives are generated).  Several options exist for decreasing the 
number of false positives generated in a microarray experiment.  Option 1 is to decrease 
the p-value cutoff, making the criteria for calling a gene “differentially expressed” more 
stringent.  Option 2 is to apply a correction for multiple testing to the list of differentially 
expressed genes.  A Bonferroni correction is the traditional method used to decrease the 
false positive rate in scientific data; however, it has been deemed too conservative for 
microarray data because it often generates false negatives at the expense of controlling 
false positives (Manly et al., 2004).  Therefore, the focus has shifted in microarray 
experiments from controlling the false positive rate to controlling the false discovery rate 
(FDR).  The FDR is the proportion of significant features (in the case of microarrays, 
genes identified as significantly differentially expressed) that are truly null (Benjamini 
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and Hochberg, 1995; Storey, 2003).  In other words, an FDR of 0.3 means that out of 100 
features (genes) deemed “significant” (using a specific p-value cutoff), 30 are potentially 
false positives.  Storey proposed a modified version of the FDR called the positive FDR 
(pFDR) that generates a q-value for each feature as a measure of the feature’s probability 
of being a false positive when called significant (Storey, 2003).  The q-value is calculated 
based on the distribution of p-values, simultaneously considering that there are thousands 
of hypotheses being tested at once (Storey and Tibshirani, 2003).  The pFDR correction 
can be applied to existing microarray data sets through the program QVALUE, which is 
freely available at http://faculty.washington.edu/~jstorey/qvalue/. 
An extension of the t-test is the ANalysis Of VAriance (ANOVA) or F-test.  
Regarding microarray data, an F-test can be used to identify differentially expressed 
genes between three or more experimental conditions.  Although it is possible to do a 
series of pair wise t-tests among the three or more experimental conditions (each 
represented by n samples) to identify differentially expressed genes, the chance of 
making a Type I error (generating false positives) increases as the number of t-tests 
increases.  An F-test controls this error by comparing the means (and variances) of all n 
samples at once.  As with the t-test, if the variance among samples is greater than the 
variance within them, it indicates that at least one of the experimental conditions differs 
(significantly) from all the rest (but it does not indicate which condition is different) 
(Churchill, 2004). 
Not all microarray experimental designs are as simple as comparing two or three 
experimental conditions to one another.  Experimental designs that incorporate a time 
course (such as studying the cell cycle, circadian rhythms or the effects of a drug over 
time) present a unique challenge when it comes to applying the appropriate statistical 
tests to them to identify differentially expressed genes.  Genes are no longer just up- or 
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down-regulated compared to control—they are now regulated at one or several time 
points, that when taken together, represent expression patterns.  Some genes will be up- 
or down-regulated at a single time point while others will be regulated at several time 
points.  While an F-test could be applied to temporal data to identify gene expression 
differences among all the time points, it would not identify at which time points the 
expression differences existed.  What is needed is a statistical test, that when applied to 
the microarray dataset, could classify differentially expressed genes as a function of time, 
according to their specific pattern of expression.  Johansson et al. used Partial Least 
Squares (PLS) regression analysis (developed by Herman Wold) to accomplish this 
(Johansson et al., 2003).  They were interested in identifying genes whose transcription 
was coupled to the yeast cell cycle.  They used PLS to derive a response model that 
described an expected expression profile over time for periodically transcribed genes.  
Their model included two possible expression patterns—one matching a sine curve and 
the other matching a cosine curve.  They applied the microarray results of three different 
yeast studies to their cell cycle models and found the same group of genes to be cyclically 
expressed in all three data sets.  These same principles could be applied to time course 
data following the administration of a drug that causes known physiological and 
behavioral changes in the organism at specific time points.  A defined set of biologically 
relevant expression patterns could be modeled using PLS, then the gene expression data 
could be fit to these patterns, producing a list of genes whose expression matched one of 
the pre-defined patterns.   
The t-test, F-test and PLS analysis are three statistical tests that can perform 
complementary functions when applied to microarray data, especially when a time course 
is involved.  It is important to apply the appropriate statistics with enough biological 
replicates to truly detect differential gene expression in a microarray experiment.  This is 
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especially true when it comes to studying diseases of the brain.  Important gene 
expression changes in the brain can be subtle, due to the changes occurring in a less well-
represented cell type or as a result of an insult such as alcohol (it is well documented that 
alcohol causes many small changes in brain gene expression, as opposed to few large 
changes) (Nisenbaum, 2002; Pavlidis, 2003; Mirnics and Pevsner, 2004).  Therefore, the 
ability to identify small but significant changes in gene expression is key in order to 
prevent false negatives and generate new hypotheses about the biology of the nervous 
system. 
Statistical analysis of the microarray data included the application of t-tests, F-
tests and Partial Least Square (PLS) analyses to identify significant changes in gene 
expression.  All statistical analyses were performed using a combination of internally 
developed algorithms, R and R packages (Gentleman et al., 2004) from CRAN 
(Comprehensive R Archive Network (http://cran.r-project.org/)) and BioConductor 
(Gentleman et al., 2004; Carey et al., 2005).  More specifically:  Thirteen t-test 
comparisons (7 n arrays per group) were run including B6 control versus D2 control and 
B6 or D2 control versus a single B6 or D2 alcohol time point (respectively).  Non-paired, 
two-tailed, equal variance t-tests were run using the mt.teststat vignette within the 
multtest package (v1.5.2) in R.  Two F-tests were run, one for B6 and one for D2.  Each 
F-test consisted of a control group and four alcohol treatment groups, with 7 n arrays per 
group.  Two-tailed F-tests were run using the mt.teststat vignette within the multtest 
package (v1.5.2) in R.  To correct for multiple testing in the t- and F-tests, the FDR was 
calculated and represented as a q-value for each gene (Storey and Tibshirani, 2003).  Q-
values were calculated based on the distribution of p-values for each t-test comparison 
and for each F-test group comparison (QVALUE software; 
http://faculty.washington.edu/~jstorey/qvalue/).  Fold change was calculated as follows:  
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fold change = 2^((average of log2 (intensity) of 7 n of second group in pair wise 
comparison) – (average of log2 (intensity) of 7 n of first group in pair wise comparison)).  
If fold change < 1, then fold change = (-1)/fold change.  In the B6 control versus D2 
control t-test, the first group was B6 and the second was D2.  In all control versus alcohol 
t-test comparisons, the first group was control and the second was alcohol.  Prior to 
running the PLS analysis, missing values were imputed using a k-nearest neighbor 
algorithm within R using the Bioconductor package “impute” and its function 
“impute.knn.”  The PLS analysis will fail if missing data points are present.  The PLS 
analysis was run using the pls2 function within the pls package in R.  PLS was run on the 
B6 and D2 time courses separately, with each PLS analysis consisting of a control time 
point and four alcohol time points.  With five time points a total of 30 possible gene 
expression patterns exist.  A binary counting algorithm was used to create 30 dummy 
codes describing each possible gene expression pattern (e.g. 00100 and 11011).  Each 
gene’s pattern of expression was fit to one of the 30 possible patterns of expression and a 
loading score was calculated which is indicative of how well the two match.  The loading 
scores allowed assignment of a single best fit pattern of expression to each gene.  The 
loading scores are converted to Z scores, then to p-values.  The smaller the p-value, the 
better the data fits the expression profile in question relative to all other genes in the 
system.  The results of the t-test, F-test, fold change, False Discovery Rate (FDR) and 
PLS analyses were loaded into the Alcohol Research Integrator (ARI) gene database 
(Bergeson et al., 2005).  The ARI database was developed to provide a means with which 
to search for specific genes, p-values, q-values, fold changes, t-test comparisons, F-test 
comparisons and PLS patterns (Figure 2.12).  Gene lists matching the search criteria can 
be downloaded from the database as a text file for further analysis. 
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To generate lists of statistically significant differentially expressed genes, gene 
lists were downloaded from the ARI database that matched the following search criteria:  
(1) For the B6 control versus D2 control query, a t-test p-value of 0.001 was used, (2) For 
the B6 and D2 control versus the two hour alcohol time point query, a t-test p-value of < 
0.05 was used and (3) For the control versus alcohol time point(s) within a single 
genotype query, a t-test p-value of 0.005 (connected by “OR” for multiple time points), 
F-test p-value of 0.05 and single PLS pattern were used.  For query #1, the genes were 
sorted by fold change (descending).  The gene list of the intoxication-related genes (#2 
above) was further filtered to maintain only those genes with directionality agreement in 
both strains.  For query #3, the 20 separate gene lists incorporating 10 different PLS 
patterns (10 patterns x 2 genotypes) represented biologically relevant patterns of gene 
expression across time, according to our model of alcohol dependence. 
Figure 2.12:  Alcohol Research Integrator (ARI) gene database search page.  An 
example of specific search criteria used to generate gene lists is shown below.  The gene 
list generated from this criteria would be the result of:  1) A t-test comparison between 
D2 control and D2 alcohol treatment at the 7 hour time point, with a p-value cutoff of 
0.005, 2) An F-test comparison of D2 control versus all D2 alcohol time points with a p-
value cutoff of 0.05 and 3) A PLS pattern within D2 where the genes are alcohol-
sensitive at the 7 hour time point only. 
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Clustering 
Microarray experiments can produce thousands to tens of thousands of data 
points, making data analysis particularly challenging.  One method used to reduce the 
large amount of data to a more easily interpretable form is to organize it into meaningful 
structures.  Cluster analysis, as it applies to microarray data, accomplishes this task by 
grouping genes with similar expression profiles together (Slonim, 2002).  Several 
different types of cluster analysis exist.  The two more commonly used clustering 
algorithms applied to microarray data are hierarchical clustering and K-means clustering.  
In both cases, a distance or similarity metric is used to determine how similar (or 
dissimilar) the expression profiles are of the genes being clustered (McShane et al., 
2003).  In hierarchical clustering, the expression profile of every gene is compared to the 
expression profile of every other gene to identify the two genes with the most similar 
expression profile, which join to form a cluster.  This process proceeds iteratively, each 
time comparing all existing clusters for similarity, then joining the most similar ones to 
create a new cluster.  The process stops when all the genes have been assigned to a 
cluster (Brazma and Vilo, 2000; Quackenbush, 2001).  Hierarchical clustering results are 
often depicted by a tree structure called a dendrogram (McShane et al., 2003).  The 
distance from one branch of the tree to the next represents the degree of similarity 
between the two elements in the branches (Quackenbush, 2001).  In hierarchical 
clustering, the number of clusters formed depends on the data and is not pre-specified, 
unlike in K-means clustering, where the algorithm is told how many clusters to generate.  
In K-means clustering, genes are randomly assigned to one of the pre-specified number 
of clusters.  Genes are moved from one cluster to another while the algorithm measures 
the similarity between their expression profiles to determine if they should remain in the 
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new cluster or be moved to a different one.  All the genes in each cluster must have 
similar expression profiles to each other and different profiles than the genes in the other 
clusters.  The process stops when the intra-cluster similarity and inter-cluster dissimilarity 
are greatest (Quackenbush, 2001).  Due to the nature of K-means clustering in that the 
data must be fit to a predefined number of clusters, K-means cluster analysis is often 
combined with techniques such as Principal Component Analysis (PCA) or PLS analysis 
that can estimate the number of clusters to which the data should be fit (Quackenbush, 
2001).  The results of cluster analysis are often displayed as a heat map, which is a 
rectangular array of colored boxes where each color represents a gene expression value in 
the sample (McShane et al., 2003; Shannon et al., 2003).  Each column of boxes 
represents an array while each row of boxes represents a gene.  The heat map contains 
patches of color that correspond to the clusters formed and are indicative of the 
expression levels of the genes within each cluster. 
One of the major reasons why cluster analysis is applied to microarray data is to 
determine the functional and/or regulatory relationship(s) between genes that cluster 
together.  Many of the cDNAs surveyed on microarrays are actually ESTs whose function 
is unknown.  By grouping ESTs with genes of known function, the function of the ESTs 
can be inferred.  The hypothesis is that genes in a cluster must share some common 
function, be part of the same pathway or have similar upstream regulatory elements 
(Quackenbush, 2001).  Two keys studies from 1998 were the first to demonstrate a 
functional and/or regulatory relationship between genes in the same cluster (Eisen et al., 
1998; Spellman et al., 1998). 
Although cluster analysis has been applied to hundreds if not thousands of 
microarray data sets to identify groups of co-regulated genes, cluster analysis does not 
have a probabilistic foundation and is therefore only an exploratory tool meant to identify 
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candidate genes for further study (Heyer et al., 1999; Shannon et al., 2003).  It cannot 
identify statistically significant differences in gene expression between experimental 
conditions (Reimers, 2005).  In addition, especially with regards to hierarchical 
clustering, clustering unrelated data will still produce clusters, which would represent 
noise as opposed to biological meaning (Quackenbush, 2001; McShane et al., 2003). 
 To visualize the patterns of expression within the 22 gene lists downloaded from 
the ARI database, a K-means clustering algorithm was applied to each of the lists.  K-
means clustering was chosen over hierarchical clustering because each gene list 
contained two distinct patterns of expression:  (1) For the control versus alcohol lists, the 
pattern contained genes that were up- or down-regulated compared to control and (2) For 
the control versus control list, the pattern contained genes that were up-regulated in either 
B6 or D2 control mice.  Prior to the application of the clustering algorithm, duplicate 
genes within each of the 20 gene lists were removed.  In addition, 31 genes were removed 
from the B6 control versus D2 control gene list because they were also alcohol-sensitive 
(present in one of the 20 control versus alcohol gene lists). 
All 22 gene lists were uploaded into the LAD to obtain log2 of R/G normalized 
ratio (median) values for each gene, which are required for the clustering program to run 
properly.  The lists were queried separately in the LAD, with the following criteria:  (1) 
For the B6 control versus D2 control gene list and for the B6 and D2 control versus the 
two hour alcohol time point gene list, the log2 ratios were obtained using B6 and D2 
arrays, in chronological order (with B6 arrays listed first). (2) For the control versus 
alcohol time points within a single genotype gene list, the log2 ratios for all 10 B6 gene 
lists were obtained using only B6 arrays, in chronological order.  The log2 ratios for all 10 
D2 gene lists were obtained using only D2 arrays, in chronological order.  The log2 ratios 
for each gene were centered by median values (which mimics the gene-wise 
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standardization procedure we use on intensity values).  The log2 ratio data was 
downloaded as .pcl files (22 files, one for each gene list) from the LAD. 
The .pcl files were opened one at a time in Cluster 3.0 (http://bonsai.ims.u-
tokyo.ac.jp/~mdehoon/software/cluster/software.htm#ctv) (de Hoon et al., 2004) and K-
means clustering was applied to each.  Clustering was performed on the x-axis only 
(genes, not arrays) with a specification of 2 clusters (because each PLS pattern is bi-
directional with respect to control or bidirectional between genotypes) and a similarity 
metric of (Pearson) correlation (uncentered).  The number of runs specified was 100 and 
the algorithm was run several times to obtain the highest number of solutions found (the 
number of times the same cluster result was found).  The output file from Cluster 3.0 is a 
.cdt file.  Each .cdt file was opened in Java TreeView (Saldanha, 2004) to visualize and 
process each cluster.  For aesthetic purposes, the red/green orientation of some of the 
clusters had to be reversed.  The reversal of the red and green colors did not affect the 
data.  Once the clusters were in the correct orientation, x and y coordinates were specified 
to size the cluster correctly, at which point the clusters were exported as .png thumbnail 
images. 
To generate the images of non-clustered genes that correlate with the clustered 
images, 20 gene lists were re-loaded into the LAD.  The 20 gene lists were either the 
original gene list or the newly sorted list, based on whether the cluster image had to be 
reversed.   The log2 of R/G normalized ratio (median) values were downloaded from the 
LAD for each gene in all lists in a similar fashion as stated above, with one exception:  
The log2 ratios for all 10 B6 gene lists were obtained using only D2 arrays, whereas the 
log2 ratios for all 10 D2 gene lists were obtained using only B6 arrays.  20 “fake” .cdt 
(non-clustered) files were visualized in TreeView and saved in a similar fashion as above.  
Thus, the order of genes in the clustered images matches that of the non-clustered images. 
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BIOINFORMATICS 
Functional analysis 
The differential gene expression profile of an organism in response to an 
experimental condition can only begin to give insight into the biology of that condition.  
It is often difficult to determine what type(s) of biological processes are occurring at the 
cellular level based on gene names alone, especially if hundreds of genes are 
differentially expressed.  Functional classification of co-expressed genes is a method 
toward understanding more about the global cellular response to a particular experimental 
condition.  Functional classification can accomplish the following:  1) Determine whether 
the co-expressed genes are functionally related, 2) Predict the function of uncharacterized 
genes and ESTs, 3) Correlate the identified functions with physiological or behavioral 
phenotypes occurring in the organism at the same time and 4) Give insight into which 
genes should be prioritized for further analysis.  
Several years ago the Gene Ontology (GO) Consortium was created to produce a 
“structured, precisely defined, common, controlled vocabulary for describing the roles of 
genes and gene products in any organism” (Ashburner et al., 2000; Harris et al., 2004).  
Within the GO database, genes are classified in three different ways:  according to their 
molecular function, biological process or cellular location.  The GO database 
(http://www.geneontology.org) is a useful tool to functionally classify large numbers of 
genes simultaneously.  Whereas the GO database classifies genes according to their 
function, the Kyoto Encyclopedia of Genes and Genomes (KEGG; 
http://www.genome.jp/keg) (Kanehisa, 1997; Ogata et al., 1999) and BioCarta 
(http://www.biocarta.com) databases classify genes according to which biochemical 
pathway they belong.  All three of these databases, and many others like them, provide 
useful insight into the functional nature of a co-expressed list of genes. 
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In recent years, statistics began to be incorporated into the functional 
classification of genes as a measure of how significant the identified functional groups 
were.  The functional groups associated with a reference group of genes (all the genes on 
the array or all the genes in an organism, for example) are compared to the functional 
groups associated with list of differentially expressed genes.  For each functional group 
associated with the list of expressed genes, a p-value is calculated that represents the 
probability that that functional group could have been identified by chance, considering 
its prevalence in the reference list of genes (Wu et al., 2002; Beissbarth and Speed, 
2004). 
WebGestalt (WEB-based GEne SeT AnaLysis Toolkit; 
http://genereg.ornl.gov/webgestalt) (Zhang et al., 2005) is an online data mining system 
for large gene sets that incorporates statistical analysis into the GO, KEGG and BioCarta 
database results.  Two options for statistical tests are available:  the hypergeometric test 
and Fisher’s exact test.  The tests are used to determine whether the functional categories 
present in the gene list are significant or occur by chance due to their prevalence in the 
reference gene list.  The user can select at what p-value the functional annotations are 
deemed significant and also the minimum number of genes that must compose a 
functional category before it can be deemed significant. Significant functional groups are 
colored red in the results output of the GO, KEGG and BioCarta database queries. 
Transcripts that passed the statistical thresholds were functionally annotated using 
WebGestalt followed by overrepresentation analysis.  The 20 B6 and D2 gene lists were 
combined (within genotype only) in different ways to create new gene lists, each 
representing a different biological process (intoxication, withdrawal or neuroadaptation) 
occurring in the mouse as a result of the experimental paradigm.  See Table 4.2 for the 
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PLS patterns composing each biological process.  The new gene lists are genotype-
specific and contain both up- and down-regulated genes compared to saline control. 
Three gene set organization sub-modules within WebGestalt were used to 
functionally classify gene lists:  1) GOTree (Zhang et al., 2004), 2) KEGG Table and 
Maps and 3) BioCarta Table and Maps.  The gene identifier used to query functional 
information in WebGestalt was gene symbol.  WebGestalt compared the lists of 
differentially expressed genes with a reference list of genes to identify overrepresented 
functional categories.  The reference list was all the genes entered into the ARI database.  
This list contained 10,977 unique gene symbols.  Significance was set at a 
hypergeometric test p-value cutoff of 0.05 and a minimum of three genes within each 
functional group annotation.  Within the GOTree module, the classification type chosen 
to represent function was Biological Process.  Significant functional categories that were 
non-specific (eg “cellular physiological process”) were excluded from the results.   
Transcription Factor Binding Site (TFBS) analysis 
Transcription factors regulate gene expression by binding to specific DNA 
sequences upstream of the transcription start site and initiating transcription.  These 
sequences are referred to as Transcription Factor Binding Sites (TFBSs).  It has been 
hypothesized that genes that are co-expressed (share the same expression profile) are also 
(potentially) co-regulated (share the same TFBSs) (Brazma and Vilo, 2000; Allocco et 
al., 2004).  Several studies have explored this relationship and found evidence to support 
this hypothesis.  Hannenhalli and Levy showed that functionally linked interacting 
proteins had a higher proportion of shared TFBSs than proteins that do not interact 
experimentally (Hannenhalli and Levy, 2003).  Allocco et al. found that genes with 
highly similar expression profiles or functional annotations were more likely to share a 
common transcription factor than those that were unrelated (Allocco et al., 2004).  
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Several investigators have provided indirect evidence for this hypothesis by 
demonstrating that clustered genes often share common upstream sequence motifs 
(Allocco et al., 2004).   
By searching for common TFBSs among genes with similar expression profiles, 
insight can be gained into the composition and function of the underlying regulatory 
networks responsible for altering gene expression as a result of a particular experimental 
condition.  The presence of a TFBS upstream of a gene does not necessarily mean that its 
concomitant transcription factor is important for the regulation of that gene, but it does 
guide further analysis. 
As with functional analysis, TFBS analysis has also been recently subjected to the 
application of statistics to identify significant TFBSs in a differentially expressed set of 
genes relative to a reference set (all the genes on the array or all the genes in an organism, 
for example).  oPOSSUM v1.3 is an online program that identifies statistically 
overrepresented TFBSs in gene promoters (Ho Sui et al., 2005).  The program identifies 
TFBSs by using Position Specific Scoring Matrices (PSSMs) and phylogenetic 
footprinting.  PSSMs are a measure of the binding specificity of a transcription factor to 
its DNA binding motif.  Because TFBS motifs are often short and degenerate, the use of 
PSSMs alone to identify them often results in a high false positive rate.  To address this 
issue, oPOSSUM searches for TFBSs only in conserved and non-coding regions.  This 
tactic, called phylogenetic footprinting, is based on the assumption that functional non-
coding sequences are more likely to be conserved across closely related species than non-
functional sequences.  This method eliminates about 80% of the sequence that would 
otherwise be used to search for TFBS; however, it has been estimated that when 
comparing mouse and human sequences, the proportion of TFBSs occurring within 
conserved regions is about 70% (Ho Sui et al., 2005). 
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oPOSSUM uses two different complementary statistical tests to identify 
overrepresented TFBSs:  a Z-score calculation and a one-tailed Fisher exact probability.  
The results output includes a list of the transcription factors that bind to the 
overrepresented TFBSs along with the differentially expressed genes from the input list 
that contain that TFBS sequence.  The transcription factors are ranked in two ways—
according to their Z-score and their p-value (from the Fisher exact probability).  Several 
user-defined parameters, including the level of conservation, matrix match threshold and 
number of base pairs upstream and downstream from the transcription start site, guide 
oPOSSUM in its search for TFBSs. 
TFBS analysis was performed using oPOSSUM to determine whether genotype-
specific differentially expressed genes contained unique TFBSs and therefore may be 
under the control of unique transcription factors.  Intoxication-related, strain-specific 
gene lists were divided into four groups:  (1) B6-up, (2) B6-down, (3) D2-up and (4) D2-
down and entered into oPOSSUM.  oPOSSUM compared the lists of differentially 
expressed genes with a reference gene list (all the genes entered into the ARI database) to 
identify overrepresented TFBSs.  A custom analysis was run in oPOSSUM with the 
following parameters:  1) Taxonomic supergroup:  vertebrate, 2) conservation level:  
30%, 3) matrix match score:  85%, 4) upstream sequence length:  2000 base pairs, 5) 
downstream sequence length:  500 base pairs.  Significance was set at a Fisher p-value of 
< 0.05 and/or a Z-score of 7 or greater.  It should be noted that some TFBSs (e.g. HNF-3 
beta and HFH-3) have similar consensus sequences. 
Cellular classification of differentially expressed genes 
Differentially expressed genes were examined for their enrichment in different 
neuronal populations.  The method used was similar to that of (Ponomarev et al., 2006) 
and is briefly described here.  Significant genes were queried in the Mouse Neuronal 
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Expression Database (MNED, http://mouse.bio.brandeis.edu) and their values in seven 
neuronal cell types (three excitatory (glutamate) and four inhibitory (GABA)) from 
cerebral cortex were retrieved (Sugino et al., 2006).  Genes that had a difference in 
expression of 2-fold or higher across the seven neuronal populations in the MNED were 
clustered using K-means cluster analysis.  A chi square analysis was applied to the genes 
enriched in the excitatory and inhibitory cell populations to determine whether a 
significant difference existed in the PLS pattern distribution between the two populations. 
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CHAPTER 3:  GENERATION OF MICROARRAY TARGETS BY 
DIFFERENTIAL DISPLAY 
Introduction 
The human and mouse genomes both contain 25,000 to 30,000 genes, of which 
99% are similar in sequence.  Therefore it is likely the expression of those genes that 
makes the human and mouse appear so different (Waterston et al., 2002).   
The complete sequence of the mouse (C57BL/6J) genome was not published until 
late 2002  (Waterston et al., 2002).  Therefore, the initial clone sets purchased for the 
cDNA microarray analysis were incomplete and did not represent the entire mouse 
transcriptome.  An mRNA differential display (DD) screen was performed to search for 
novel differentially expressed genes in the B6 and D2 mice as a result of acute alcohol 
exposure.  The goal was to generate previously uncharacterized genetically divergent and 
alcohol-sensitive transcripts that could be added to the cDNA microarrays as additional 
targets.  Several attributes of DD made it an attractive choice for this purpose:  1) it is an 
unbiased technique that allows novel transcripts to be detected that may not have been 
intuited by a hypothesis-driven approach, 2) it is highly sensitive and can detect 
expression differences as small as 20%, 3) it allows a reasonably complete representation 
of all the genes in a sample to be seen, including some “rare” transcripts, 4) it can detect 
sequence polymorphisms, insertions and deletions, as well as absolute differences in 
expression. 
Two biologically relevant time points (two hours and six hours) were chosen to 
search for genetically divergent, alcohol-sensitive changes in gene expression as a result 
of acute alcohol administration.  The two hour time point represents the state of 
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intoxication and the six hour time point represents the state of physical dependence (6-8 
hours post acute alcohol administration is the peak of withdrawal). 
Results 
The DD screen identified differentially regulated known genes, ESTs and 
previously uncharacterized transcripts between the B6 and D2 mice and as a result of 
alcohol exposure.  Approximately 1.3% percent of the total genes screened were 
differentially regulated.  Of these, about 24% represented genetic differences between the 
strains, 45% represented alcohol-sensitive differences and 36% were a combination of 
both.  Figures 3.1 and 3.2 show two of the differentially expressed genes identified in the 
DD screen. 
Figure 3.1:  Example of an alcohol-related gene identified by DD.  2-oxoglutarate 
dehydrogenase is expressed 2 hours and 6 hours post acute alcohol administration.  This 
gene was not included in any of the purchased cDNA clone sets and therefore represents 
a novel additional target printed on the microarrays as a direct result of the DD screen. 
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Figure 3.2:  Example of a genetically divergent, alcohol-related gene identified by 
DD.  N-deacetylase/N-sulfotransferase is expressed at 2 hours in both strains, with 
slightly higher expression in the B6 mouse.  It is also expressed at 6 hours post acute 
alcohol administration, but only in the D2 strain. 
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 The clones isolated from the DD screen were PCR amplified prior to their 
addition as targets on the microarrays.  A small portion of the PCR product was run on an 
agarose gel to ensure the presence of a single band (and therefore no contamination).  
Any clone with greater than one band was either re-run or discarded as a potential target.  
Figure 3.3 shows a sampling of DD clones on an agarose gel, most of which were added 
to the microarrays. 
Figure 3.3:  Agarose gel with PCR products of amplified DD clones.  Most of the 
clones contained a single band and were therefore cleared as new targets to be printed on 
the microarrays. 
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The DD clones added to the microarrays represent about 150 unique known 
genes, ESTs and unknown sequences (Table A.1).  Many of them are not included in any 
of the purchased clone sets and therefore are unique targets that are only present on the 
arrays as a result of the DD screen.  These novel genes include: calcyphosine, 2-
oxoglutarate dehydrogenase, aczonin, catenin alpha 2, myelin proteolipid protein, minor 
histocompatibility antigen precursor, transmembrane 4 superfamily member 8, myotonic 
dystrophy kinase-related Cdc42-binding kinase and TU3A, which is a human orthologue 
of a novel mouse gene that has not yet been characterized. 
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Discussion 
The DD screen identified several novel genetically divergent and alcohol-
sensitive transcripts that would not have been included in the cDNA microarray analysis 
if they had not been discovered through DD.  Therefore, the DD clones represent 
valuable reagents that enhanced the search for gene expression differences between the 
B6 and D2 mice over a time course following an acute dose of alcohol.  DD served as a 
complementary method to the cDNA microarray analysis, allowing more genes to be 
identified and serve as candidates to hypothesis-test for a potential role in the 
development of alcohol dependence. 
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CHAPTER 4:  ALCOHOL-INDUCED TEMPORAL 
TRANSCRIPTOME REMODELING IN MOUSE PREFRONTAL 
CORTEX 
Abstract 
The role specific anatomical brain regions play in the manifestation of alcohol-
related traits and endophenotypes is poorly understood.  Autopsies have shown that the 
prefrontal cortex is selectively damaged in long-term alcoholics (Kril and Halliday, 
1999).  Therefore, we chose to study the prefrontal cortex and its role in the initiation of 
alcohol dependence using the inbred mouse strains, C57BL/6J (B6) and DBA/2J (D2).  
B6 and D2 mice differ for numerous measures of alcohol-induced outcomes, including 
alcohol dependence.  Nearly 3 million cDNA microarray data points were analyzed 
across genotype and a 24 hour time course for changes in gene expression following 
intoxication-related anesthesia and acute physical dependence induced by a single large 
dose of alcohol (4 g/kg, i.p.).  Unique genotype-specific temporal patterns of gene 
expression were identified for physiologically relevant alcohol-related consequences 
including: intoxication, withdrawal and neuroadaptation.  In silico analysis of alcohol-
sensitive genes revealed genotype-specific patterns of transcriptional regulation and 
functional activity, which may contribute to strain differences in alcohol-related 
behaviors.  Categorization of alcohol-sensitive genes by their cellular profiles 
demonstrated a divergence in gene expression between excitatory and inhibitory neurons.  
The results of the study identified genes of both known and unknown function as 
important candidates underlying the complex molecular responses to alcohol. 
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Introduction 
Alcohol is one of the most widely used drugs.  Its abuse can lead to the 
development of alcoholism (alcohol dependence), a disease with a nearly 20% lifetime 
risk in the United States (Hasin et al., 2005).  Alcoholism is classified clinically as 
including physical dependence, tolerance and a maladaptive pattern of alcohol use (APA, 
2000).  It is a complex disease influenced by both environmental factors and genetic 
predisposition (Goodwin et al., 1973; Cloninger et al., 1981; Enoch and Goldman, 2001; 
Crabbe, 2002a).  Rodent models have long been used to study specific alcohol-related 
phenotypes and are now considered valuable molecular tools.  C57BL/6J (B6) and 
DBA/2J (D2) inbred strains of mice are the most widely used mouse model to study 
alcoholism as they differ for nearly every alcohol response (Crabbe et al., 1999), 
including acute physical dependence (Buck et al., 1997). 
Gene expression analyses of several rodent models have led to a better 
understanding of alcohol-induced transcriptional response and genetic influences on 
alcohol-related traits (Xu et al., 2001; Rimondini et al., 2002; Hoffman et al., 2003; Saito 
et al., 2004; Treadwell and Singh, 2004; Bergeson et al., 2005; Edenberg et al., 2005; 
Kerns et al., 2005; MacLaren and Sikela, 2005; McBride et al., 2005; MacLaren et al., 
2006; Mulligan et al., 2006).  Each of the studies identified candidate genes, which 
individually are likely to contribute to the overall complexity of a specific alcohol-related 
behavior or physiological effect.  The results of a recent meta-analysis for alcohol 
preference underscore the value of transcriptome analysis in understanding the complex 
nature of the genetics of alcohol-related traits (Mulligan et al., 2006).  Ultimately, 
important allelic differences that contribute to unique, innate responses to alcohol need to 
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be identified.  For example, a role for Mpdz in alcohol withdrawal symptoms has been 
successfully established (Fehr et al., 2004). 
In humans, the prefrontal cortex (PFC) is associated with higher cognitive 
functions such as problem solving, critical thinking, planning, judgment and impulse 
control (Funahashi, 2001), all of which can be negatively affected by alcohol use.  The 
PFC is part of the mesocorticolimbic dopamine (DA) pathway, which is activated by 
alcohol (Bowirrat and Oscar-Berman, 2005).  Positive reinforcing properties act in the 
“reward” pathway by causing an increase in DA leading to the compulsion to drink 
(Koob, 1992).  Over time, alcohol-related selective damage to the PFC occurs, as is well 
documented in post-mortem analyses of chronic alcoholics (Kril et al., 1997; Kril and 
Halliday, 1999).  Several post-mortem expression studies in humans have shown 
significant alcoholism-related gene changes in cortex (Lewohl et al., 2000; Mayfield et 
al., 2002; Sokolov et al., 2003; Iwamoto et al., 2004; Flatscher-Bader et al., 2005; Liu et 
al., 2006).   
The primary goal of the current study was to use a standard B6,D2 mouse model 
of acute physical dependence (Buck et al., 1997) coupled with cDNA microarray analysis 
to monitor changes in PFC gene transcription over a 24 hour time course following 
alcohol administration.  Incorporation of a time course allows the gene expression 
changes concomitant with intoxication, withdrawal and neuroadaptation—three 
biologically relevant stages of acute alcohol response—to be compared.  A genotype × 
time paradigm allowed the molecular fingerprinting of genetic divergence within the PFC 
transcriptome, which may underlie phenotypic differences in the initiation and 
development of alcohol dependence between the B6 and D2 strains. 
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Materials and Methods 
ANIMALS AND ANIMAL HUSBANDRY 
Male C57BL/6J (B6) and DBA/2J (D2) mice, 70-100 days old, were group-
housed under a 12 hour light/dark cycle with food and water available ad libitum.  All 
animal procedures were IACUC approved according to NIH and AAALAC guidelines. 
EXPERIMENTAL DESIGN AND TISSUE COLLECTION 
B6 and D2 mice were habituated to injection for at least three days with a 0.5 ml 
i.p. injection of saline (0.9% sodium chloride).  On the day of the experiment, the mice 
were injected in random order with 4 g/kg, i.p. ethanol (20% v/v in 0.9% sodium 
chloride) or an equivalent volume of saline.  Alcohol-injected mice were sacrificed by 
cervical dislocation at 2, 7, 12 and 24 hours post-injection (n = 7 per group) while saline 
control mice were sacrificed at 2 hours post-injection (n = 7 per group).  The prefrontal 
cortex was dissected from whole brain and immediately frozen in liquid nitrogen within 
two minutes of sacrifice and three minutes of removal of the mouse from its home cage.  
Prefrontal cortex was isolated by making an incision along the fissura longitudinalis 
cerebri, peeling the cortex flat and dissecting the anterior portion of the brain back 1.7 
mm posterior, approximately 1.5 mm rostral to bregma, including portions of the 
following anatomical regions: agranular, cingular, frontal association, motor, orbital, pre- 
and infralimbic cortex (Franklin and Paxinos, 1997). 
RNA ISOLATION AND QUANTIFICATION 
Individual brain samples were homogenized in 1 ml of RNA STAT-60 (Tel-Test, 
Inc., Friendswood, TX) using a Polytron homogenizer (Kinematica, Lucerne, 
Switzerland).  Total RNA was isolated according to the manufacturer’s protocol.  RNA 
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was resuspended in 15 μl of nuclease-free water (Ambion, Austin, TX) and quantified 
with a NanoDrop ND-1000 UV/Vis Spectrophotometer (NanoDrop Technologies, 
Wilmington, DE).  The quality of the RNA was determined using an Agilent 2100 
Bioanalyzer (Agilent Technologies, Palo Alto, CA).  Samples were stored at –70ºC.   
CDNA MICROARRAY FABRICATION AND HYBRIDIZATION 
Clones printed on the University of Texas at Austin custom cDNA microarrays 
included the NIH BMAP UniGene library (~11,000 clones), Sequence Verified IMAGE 
clones (~5000) (ResGen/Invitrogen, (Carlsbad, CA) and The National Institute of Aging 
(~22,000) cDNA clone set.  Based on assignment to Unigene clusters, approximately 
25,000 distinct genes were represented in the clone sets.  cDNA clones were amplified by 
polymerase chain reaction (PCR) and printed on poly-L-lysine coated glass microscope 
slides (Gold Seal, Erie Scientific Co., Portsmouth, NH) using an arraying robot as 
previously reported (DeRisi et al., 1997). 
Cy-dye-labeled cDNA was generated from 500 ng of total RNA using the 3DNA 
Array 900 kit (Genisphere, Hatfield, PA) according to the manufacturer’s protocol.  
Sample cDNA from alcohol-treated or saline control animals (Cy3-labeled) was always 
hybridized against a Cy5-labeled standard reference (whole brain RNA isolated from 100 
male B6 mice).  The dye-labeling procedure and all subsequent steps were performed 
under minimal lighting conditions.   
Hybridization took place in humidified chambers that fit up to 10 microarray 
slides (Genetix Limited, United Kingdom).  Chambers were balanced for groups and no 
more than two chambers were used simultaneously.  Ozone degradation of dye was 
prevented by keeping slides in an argon atmosphere following hybridization and prior to 
scanning.  Slides were scanned using a GenePix 4000A or B scanner and spots were 
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labeled and quantified using SpotReader (Niles Scientific, Portola Valley, CA) and/or 
GenePix Pro 5.1 (Axon Instruments, Inc., Union City, CA). 
The overall rate of post-hoc confirmation of single gene expression for our cDNA 
platform is greater than 80% (Bergeson lab, unpublished results and see also (Ponomarev 
et al., 2006)). 
NORMALIZATION AND STORAGE OF MICROARRAY DATA 
Microarray normalization was performed using the R (Ihaka and Gentleman, 
1996) package: Statistics for Microarray Analysis (Yang et al., 2002).  Specifically, the 
lowess within-print-tip-group function was used for normalization. A program developed 
in our lab that automates the normalization procedure was used to apply the normalized 
values to GenePix Results (GPR) files. The normalized GPR files were uploaded and 
stored in the Longhorn Array Database (LAD) (Killion et al., 2003). 
RETRIEVAL AND STANDARDIZATION OF MICROARRAY DATA 
Microarray data was retrieved from the LAD as net (background-subtracted) 
median intensity values.  The Channel 1 (Ch1 (alcohol-treated or control Cy-3 labeled 
sample)) and Channel 2 (Ch2 (reference Cy-5 labeled sample)) intensities of every gene 
(39,335) on all 70 arrays were downloaded as two separate text files.  The two files were 
converted to log2 scale so that the following equation could be applied (on a per gene 
basis) to standardize all arrays to each other: 
Ch1adj = Ch1 + (Ch2med – Ch2) 
Ch1adj is the adjusted Ch1 log2 intensity for each spot, Ch1 is the original Ch1 
log2 intensity for that spot, Ch2med is the median log2 Ch2 intensity of all of the spots for 
that gene, and Ch2 is the individual log2 Ch2 intensity of each of the spots for that gene.  
Since all of the microarrays were hybridized with the same sample in Ch2, the Ch1 
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intensities can be directly compared when adjusted proportionally with the median (or 
average) Ch2 intensity across all arrays being compared. This technique allows the 
microarrays to be analyzed without the use of ratios, and allows for the comparison of 
any condition to any other condition and across experiments as long as the same 
reference sample was used on all of the arrays. The output of the standardization 
procedure is a single file with adjusted Ch1 intensities for all of the microarrays 
originally downloaded.  An outlier test was run for each group to remove spots that were 
+/- two standard deviations from the group mean.  Outliers were replaced with blanks and 
genes with fewer than six values were removed leaving 36,694 clones.  Finally, an 
intensity filter was applied to maintain only those genes with at least one group mean 
intensity of 25 or greater, leaving 26,418 genes for further analysis. 
DATA ANALYSIS AND STATISTICAL METHODS 
Statistical analysis of the microarray data included the application of t-tests, F-
tests and Partial Least Square (PLS) analyses to identify significant changes in gene 
expression.  The t-tests (non-paired, two-tailed, homoscedastic) were used to compare 
control versus control or control versus alcohol samples.  The F-tests (two-tailed) were 
used to compare all time points (samples of control through 24 hours) within a single 
genotype.  PLS analysis was performed using all possible fit models (patterns) for the 
defined data set, which was calculated using a binary counting algorithm that yielded 
dummy codes to describe each pattern for each test (i.e. – 00011 for five comparisons, 
with each number corresponding to a control or alcohol-related time point).  All statistical 
analyses were performed using a combination of internally developed algorithms, R and 
R packages (Gentleman et al., 2004) from CRAN (http://cran.r-project.org) and 
BioConductor (Gentleman et al., 2004; Carey et al., 2005).  Fold change was calculated 
by comparing group averages of control arrays to alcohol arrays (or control to control).  
 115
The results of these analyses were loaded into the Alcohol Research Integrator database 
(ARIdb) (Bergeson et al., 2005).  K-means cluster analysis was performed using Cluster 
3.0 (de Hoon et al., 2004) (http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/ 
cluster/software.htm) and cluster images were generated using Java TreeView (Saldanha, 
2004). 
Gene lists were downloaded from the ARIdb that matched the following search 
criteria:  (1) For the B6 control versus D2 control query, a t-test p-value of < 0.001 was 
used, (2) For the B6 and D2 control versus the two hour alcohol time point query, a t-test 
p-value of < 0.05 was used and (3) For the control versus alcohol time point(s) within a 
single genotype query, a t-test p-value of < 0.005, F-test p-value of < 0.05 and single PLS 
patterns were used.  The gene list of the intoxication-related genes (#2 above) was further 
filtered to maintain only those genes with directionality agreement in both strains.  For 
query #3, the 20 separate gene lists incorporating 10 different PLS patterns (10 patterns x 
2 genotypes) represented biologically relevant patterns of gene expression across time, 
according to our model of alcohol dependence. 
TRANSCRIPTION FACTOR BINDING SITE (TFBS) OVERREPRESENTATION ANALYSIS 
The oPOSSUM database was used to analyze transcription factor binding sites 
(TFBS) that were overrepresented in up- or down-regulated intoxication-related genes 
(Vadigepalli et al., 2003; Ho Sui et al., 2005).  The following parameters were chosen for 
each gene list entered into oPOSSUM:  1) Taxonomic supergroup:  vertebrate, 2) 
conservation level:  30%, 3) matrix match score:  85%, 4) upstream sequence length:  
2000 base pairs, 5) downstream sequence length:  500 base pairs.  Overrepresented 
binding sites were determined for each group of genes based on one-tailed Fisher exact 
probabilities (Fisher p-values) and Z-scores.  Significance was set at Fisher p < 0.05 
and/or Z score > 7.  Determination of a non-random association of the TFBS used Fisher 
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p-values for a comparison of the proportion of target genes (co-expressed genes) 
containing a specific TFBS to the proportion of background genes (all genes entered into 
the ARIdb) for that TFBS.  The number of times a TFBS appeared in a promoter region 
was irrelevant. The Z-score, however, compared the rate of every occurrence of a TFBS 
in target genes with the rate of each occurrence in background genes.  It should be noted 
that some TFBS (e.g. HNF-3 beta and HFH-3) have similar consensus sequences. 
Note that the gene lists used to query the oPOSSUM program were last annotated 
in July 2005. 
FUNCTIONAL OVERREPRESENTATION ANALYSIS 
Transcripts that passed the statistical thresholds were functionally annotated using 
WebGestalt (WEB-based Gene SeT AnaLysis Toolkit, 
http://genereg.ornl.gov/webgestalt) followed by overrepresentation analysis (Zhang et al., 
2005).  Functional annotations were based on Gene Ontology (GO) Consortium 
(http://www.geneontology.org) (Ashburner et al., 2000; Harris et al., 2004), BioCarta 
pathways (http://www.biocarta.com/genes/index.asp) and the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database (http://www.genome.jp/kegg) (Kanehisa, 1997; 
Ogata et al., 1999).  WebGestalt used a hypergeometric test to determine whether the 
functional categories represented in the gene lists were significant or occurred by chance 
based on their prevalence in the background gene list (all genes entered into the ARIdb).  
Significance was set at p < 0.05 and a minimum of three genes within each functional 
group annotation.  Significant functional categories that were non-specific (eg “cellular 
physiological process”) were excluded from the results. 
Note that the gene lists used to query WebGestalt were last annotated in July 
2005. 
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CELLULAR CLASSIFICATION OF DIFFERENTIALLY EXPRESSED GENES 
Differentially expressed genes were examined for their enrichment in different 
neuronal populations.  The method used was similar to our previous report (Ponomarev et 
al., 2006) and is briefly described here.  Significant genes were queried in the Mouse 
Neuronal Expression Database (MNED, http://mouse.bio.brandeis.edu) and their values 
in seven neuronal cell types (three excitatory (glutamate) and four inhibitory (GABA)) 
from cerebral cortex were retrieved (Sugino et al., 2006).  Genes that had a difference in 
expression of 2-fold or higher across the seven neuronal populations in the MNED were 
clustered using K-means cluster analysis.  A chi square analysis was applied to the genes 
enriched in the excitatory and inhibitory cell populations to determine whether a 
significant difference existed in the PLS pattern distribution between the two populations. 
Note that the gene lists used to query the MNED were last annotated in July 2005. 
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Results and Discussion 
STRAIN SPECIFIC TRANSCRIPTOME FINGERPRINTS RESULT FROM ALCOHOL 
EXPOSURE 
Transcriptional responses to alcohol, regardless of dose or the mode of exposure, 
encompass a range of time points, from initial exposure and intoxication to the time the 
alcohol clears the system to the short and long-term consequences that follow.  Previous 
studies examining the effects of alcohol exposure on the rodent brain transcriptome have 
focused on a single time point following a specific alcohol treatment (Daniels and Buck, 
2002; Rimondini et al., 2002; Saito et al., 2004; Treadwell and Singh, 2004; Kerns et al., 
2005; Rulten et al., 2006).  The goal of the present study was to identify PFC-specific 
temporal patterns of alcohol-related gene expression in a standard mouse model of acute 
dependence (Buck et al., 1997).  Microarray analyses of 2, 7, 12 and 24 hour post-alcohol 
injection time points were completed, which reflect the biological processes related to 
intoxication, peak of withdrawal, recovery and neuroadaptation, respectively.  At two 
hours post injection of 4 g/kg i.p. ethanol, B6 and D2 mice were visibly intoxicated, 
showing little movement but when active, a severely impaired gait.  Seven hours is within 
the published peak of withdrawal for the acute dependence model with handling-induced 
convulsion (HIC) scores returning to baseline by 12 hours (Buck et al., 1997).  None of 
the mice used were tested for withdrawal signs so that HIC-related confounds would not 
alter gene expression.  In order to assay for longer-term or neuroadaptive expression 
changes, a 24 hour time point was included. 
PLS analysis coupled with statistical tests for significance (t-test and F-test) were 
used to fit ten biologically relevant patterns of expression, with the nodes in each PLS 
pattern corresponding to the control, 2, 7, 12 and 24 hour time points, respectively 
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(Figure 4.1).  Cluster analysis within each PLS class revealed genetically distinct alcohol 
expression responses, which are shown as a pseudo-color raster display in Figure 4.1.  
The genes significantly changed in B6 mice (386) are shown in the left panel of Figure 
4.1A while those changed in D2 mice (354) are displayed in the right panel of Figure 
4.1B.  Gene identities are listed in Table A.2.  The striking patterns of change indicate 
that genetically divergent transcriptome remodeling occurred continuously across the 
assayed time course.  Categorization of the genes according to their unique 
transcriptional profile allowed genes that change only at the two hour time point 
(intoxication) to be distinguished from those that change at the two hour time point and 
remain changed throughout the time course (neuroadaptation).  The PLS patterns allowed 
unique insight into candidate genes likely to play a role in intoxication, withdrawal, 
recovery and neuroadaptation.    The significance of the findings was that considerable 
transcriptome remodeling occurs in the PFC following a single alcohol exposure. 
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Figure 4.1:  Alcohol-related strain differences in gene expression as a function of 
time.  A total of 386 (A; left panel) and 354 (B; right panel) genes were differentially 
expressed as a result of alcohol exposure in B6 and D2 mice respectively.  K-means 
cluster analysis revealed the up- (green) and down- (red) regulation of differentially 
expressed genes within each temporal pattern of expression.  Values of clustered genes 
are displayed in the opposite strand (A; right panel and B; left panel) to show that 
expression patterns are strain-specific.  Rows represent genes and columns represent 
arrays, with each time point corresponding to seven arrays.  Gene names are listed in 
Table A.2 and are current as of July 31, 2006. 
Figure 4.1:  Alcohol-related strain differences in gene expression as a function of 
time. 
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To determine whether the differentially expressed genes in one genotype followed 
the same temporal expression pattern in the other genotype, the values of the significant 
genes in the B6 and D2 strains were queried in the D2 and B6 strains (respectively), 
maintaining gene order.  Interestingly, very few genes (~30) overlapped between the B6 
and D2 mice at the stringent significance level chosen (p < 0.005).  The right panel of 
Figure 4.1A and the left panel of Figure 4.1B show the gene values in the opposite or 
non-clustered strain.  No expression patterns were apparent, indicating that the two 
mouse strains have unique alcohol-associated transcriptional fingerprints.  The genes that 
contribute to the distinct patterns between B6 and D2 represent candidate genes that may 
play a role in the dependence-related phenotypic differences between the strains. 
A genetic divergence clearly existed between the transcriptional consequences of 
an acute dose of alcohol in B6 and D2 mice.  However, previous studies have shown that 
the strains contain genetic factors that contribute to both high and low responses for 
several alcohol-related phenotypes, suggesting that at least some genes should be 
expressed similarly between the strains in response to alcohol (Phillips et al., 1994; Buck 
et al., 1997; Metten et al., 1998; Crabbe et al., 2005).  We searched for genes with similar 
expression in B6 and D2 PFC in response to alcohol intoxication (t-test p-value < 0.05 
and fold change directionality agreement in both strains).  A total of 84 alcohol-
dependent, genotype-independent changes in gene expression were observed.  Cluster 
analysis indicated that the genes were similarly expressed in both strains across all time 
points following alcohol exposure (Figure 4.2; see Table A.3 for the gene names).  The 
patterns of B6 and D2 gene expression were consistent with previous behavioral data that 
suggests that neither strain can be simply or categorically labeled as sensitive or resistant 
to the effects of alcohol (Crabbe et al., 2005).  The similarly expressed genes may 
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explain, in part, non-maximal phenotypic dissimilarity between the two inbred strains for 
acute alcohol withdrawal and other alcohol-related responses. 
Figure 4.2:  General expression responses following intoxication.  K-means cluster 
analysis was applied to 84 genes differentially expressed in both B6 and D2 two hours 
post-alcohol exposure (t-test p-value < 0.05) with fold change directionality agreement.  
A pattern indicative of genotype-independent alcohol-related gene expression was 
revealed.  Green and red boxes represent genes up- or down-regulated by alcohol 
compared to control, respectively.  Rows represent genes and columns represent arrays, 
with each time point corresponding to seven arrays.  Gene names are listed in Table A.3 
and are current as of July 31, 2006. 
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Alcohol insensitive, genetically divergent expression can contribute to alcohol-
related traits, e.g. as a genetic predisposition.  Naïve strains and lines of mice have 
provided insight into the genetics of alcohol-related traits such as sensitivity and acute 
functional tolerance (Xu et al., 2001; Tabakoff et al., 2003).  We compared B6 and D2 
control mice to identify genetic differences in gene expression between the PFC of the 
two strains.  One hundred twenty-six genes showed significant genetic divergence 
between B6 and D2 mice with no alcohol-associated expression response (Figure 4.3; see 
Table A.4 for the gene names).  Approximately 60% of the expression differences were 
higher in B6 than D2 mice which might indicate the presence of allelic differences in 
general control factors.   
A recent meta-analysis of nine mouse models of alcohol preference identified 
specific candidate genes for alcohol consumption (Mulligan et al., 2006).  Thirty-one of 
the B6/D2 alcohol non-responsive genes identified in our study are consistent with these 
findings.  The genetically divergent expression differences identified in our study may be 
predisposition genes for alcohol-related traits such as susceptibility to physical 
dependence; however, at least some of the genes identified likely play a role in other B6, 
D2 divergent phenotypes. 
Figure 4.3:  Genetic differences in gene expression between B6 and D2 mice.  One 
hundred twenty-six genes showed significant genetic divergence between B6 and D2 
mice with no alcohol-associated expression response (t-test p-value < 0.001).  Green and 
red boxes represent genes more highly expressed in B6 or D2, respectively.  Rows 
represent genes and columns represent arrays, with each time point corresponding to 
seven arrays.  Gene names are listed in Table A.4 and are current as of July 31, 2006. 
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IN SILICO PROMOTER ANALYSIS IDENTIFIES A REGULATORY TFBS PATTERN FOR 
ALCOHOL INTOXICATION-ASSOCIATED GENE EXPRESSION. 
Microarray hybridization assays the relative amounts of thousands of individual 
transcripts in a sample but gives no direct information on the mechanisms responsible for 
the level of transcript detected.  Regulation of transcript concentration can take place at 
several levels; through binding of a complex of transcription factors (with either positive 
or negative activity), by chromatin remodeling, which can be mediated by covalent 
modification of DNA or histones, or through controlled stability or degradation of the 
message.  Bioinformatic tools capable of analyzing DNA sequences for transcription 
factor binding sites (TFBS) now exist and are a valuable tool for understanding the 
molecular mechanisms underlying alcohol-associated phenotypes, including acute 
alcohol withdrawal. 
Genes that show similar alcohol-related temporal expression patterns may be co-
regulated by common transcription factors.  The presence of specific transcriptional 
regulatory sequences in the 5’ upstream region of a gene indicates the potential 
complement of transcription factors that may be regulating a particular gene.  oPOSSUM 
was used to identify overrepresented transcription factor binding sites (TFBS) in genes 
expressed during intoxication.  Genes expressed at two hours post alcohol exposure were 
divided into 4 groups:  1) B6 up-regulated genes, 2) B6 down-regulated genes, 3) D2 up-
regulated genes, 4) D2 down-regulated genes, to separate out the effect of genotype and 
direction of regulation. 
oPOSSUM analysis uncovered genotype-dependent and -independent TFBS 
usage for intoxication-related increases and decreases in gene expression in the PFC 
(Table 4.1).  Alcohol-related gene expression appeared to be driven by unique sets of 
transcription factors in B6 mice; whereas in the D2 mouse, few specific TFBS were 
 128
identified.   In addition, in B6 mice, distinct differences were apparent in the regulation of 
genes with increased or decreased expression in response to alcohol intoxication.  The 
TFBS for Sp1 was present in over 50% of the genes up-regulated at two hours while c-
Myb, Gfi and Yin-Yang were abundant in the down-regulated genes.  Previous studies 
have implicated Sp1 in transcriptional control of alcohol mediated expression changes 
(Wilke et al., 2000; Rulten et al., 2006) while c-Myb, Gfi and Yin-Yang represent novel 
candidates for further study. 
General, genotype-independent, alcohol-related up-regulation shared several 
control factors in common between the mouse strains.  Increased gene expression in B6 
and D2 following exposure to alcohol was mediated, in part, by CREB, c-REL, NF-
kappaB and p65.  CREB and NF-kappaB have been confirmed in other studies (Spitzer et 
al., 2002; Hassan et al., 2003; Gukovskaya et al., 2004; Nestler, 2005) supporting our in 
silico findings.  Overall, our results indicated that genetic differences in transcriptional 
regulation following alcohol treatment exist.  While alcohol-related increases in 
expression are less genotype-dependent, decreased expression in B6 mice may be 
influenced more by the activity of unique transcription factors. 
It should be noted that each subcategory of genes (from B6 up, B6 down, D2 up 
or D2 down) highlights TFBSs that are overrepresented within that subcategory of genes 
only (compared to reference), as denoted by a colored “X” (Table 4.1).  In other words, 
genes within each subcategory may contain TFBSs other than those listed with an “X,” 
but they are just not overrepresented.  
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Table 4.1:  Transcription factor binding site (TFBS) analysis of intoxication-
associated gene expression.  oPOSSUM was used to detect overrepresentation of TFBSs 
in the 2000 base pair region upstream of the start site of all genes differentially expressed 
two hours following alcohol treatment.  Significance for overrepresented TFBSs in up- 
and down-regulation in B6 and D2 mice was set by Fisher’s p < 0.05 and/or Z score > 7.  
The y-axis (blue cells) is transcription factors that bind to (overrepresented) TFBSs.  The 
x-axis (pink cells) is the genes within each subcategory (B6 up, B6 down, D2 up or D2 
down) that contain at least one of the overrepresented TFBSs identified within that 
subcategory.  The vertical double line denotes general alcohol effects to the left and 
genetically divergent TFBS usage to the right. 
Table 4.1:  Transcription factor binding site (TFBS) analysis of intoxication-
associated gene expression. 
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FUNCTIONAL ANALYSIS UNCOVERS GENETICALLY DIVERSE, ALCOHOL-RELATED 
OVERREPRESENTATION OF BIOLOGICAL PROCESSES. 
The discovery of a strong genotype-dependent transcriptional response to a single 
high dose of alcohol led us to ask whether the response was genotype-dependent on a 
functional level as well.  Overrepresentation analysis for function was performed within 
WebGestalt (Zhang et al., 2005) using the GO Tree, KEGG and Biocarta databases.  
Genes showing significant changes in expression (Table A.2) were grouped into three 
general classes:  1) intoxication, 2) withdrawal and 3) neuroadaptation according to best 
fit PLS patterns (Table 4.2).  A dichotomy in functional themes between the B6 and D2 
mice was seen.  Several overrepresented categories in the B6 strain contained genes 
involved in signaling, while a different trend was seen in the D2 strain, where 
metabolism-related categories were more abundant.  The genetic difference may 
represent a consequence of strain divergent alcohol-related compensatory mechanisms in 
the PFC. 
Differences in functional categories were greater between genotypes than across 
classifications (intoxication, withdrawal, neuroadaptation) within genotype (Table 4.2).  
With the exception of RNA splicing and nucleic acid metabolism, no functional 
categories were consistent between the two strains.  However several categories 
overlapped between classifications within the strains.  While this may be due, in part, to 
common PLS patterns between classifications, it suggests that the cellular functional 
response to alcohol was more dependent on genotype than on the basic physiological 
effects elicited by alcohol’s presence. 
Table 4.2:  Overrepresented functional categories in B6 and D2 mice.  Genes from 
Table A.2 were divided into three groups (per genotype) to represent the physiologically 
relevant alcohol consequences of intoxication, withdrawal and neuroadaptation.  Groups 
contained both up- and down-regulated genes and the PLS patterns comprising each 
group are shown on the left.  The Gene Ontology, KEGG and BioCarta databases were 
queried within WebGestalt to identify overrepresented functional categories within each 
group of genes.  Significance was set at p < 0.05 with a minimum requirement of three 
genes per functional group.  The p-values for each overrepresented functional group are 
shown on the right. 
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ALCOHOL-RELATED GENES HAVE UNIQUE CELLULAR PROFILES IN EXCITATORY 
AND INHIBITORY NEURONS.  
To determine whether the alcohol-related genes in this study could be categorized 
by specific neuronal subtypes, we examined their expression across seven neuronal 
populations in the cerebral cortex:  three excitatory (glutamate) and four inhibitory 
(GABA).  We searched the Mouse Neuronal Expression Database (MNED) (Sugino et 
al., 2006) for the presence of differential neuronal expression of our alcohol-related genes 
(from Table A.2).  A total of 148 alcohol-related genes (70 in B6 and 78 in D2) were 
found to have an average expression difference of 2-fold or higher across the seven 
neuronal subtypes (Figure 4.4).  A K-means cluster analysis of the expression values 
from the MNED clustered the alcohol-related genes according to their enrichment in 
excitatory or inhibitory neuronal populations, suggesting that some of the genes identified 
as differentially expressed in the PFC have unique cellular profiles within that brain 
region (Figure 4.4).  It should be noted however, that the expression of many of the 
alcohol-related genes was cell-type specific and was not uniform across all three 
excitatory or all four inhibitory cell populations—a result that was not unexpected based 
on the findings of (Sugino et al., 2006).  A pseudo-color rastergram of the differentially 
expressed alcohol-related genes shows an approximate 1:1 ratio of up- to down-
regulation in both B6 and D2 within each neuronal population, suggesting that no bias 
existed towards directionality of gene expression within excitatory or inhibitory neuronal 
populations (Figure 4.4). 
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Figure 4.4:  Cellular classification of differentially expressed genes.  Alcohol-related 
genes (green and red panels) clustered according to their enrichment in different neuronal 
populations (black and yellow panels).  Expression of alcohol-sensitive genes was 
examined across seven neuronal populations in the cortex: three excitatory (glutamate 
(Glut)) and four inhibitory (GABA).  Gene symbols of alcohol-sensitive genes from 
Table A.2 were matched to data from the Mouse Neuronal Expression Database (MNED) 
(Sugino et al., 2006), and genes present in both datasets and that also showed substantial 
heterogeneity in expression among the seven neuronal populations (difference of 2-fold 
and higher) were selected.  Our search revealed 70 genes regulated in B6 (A) and 78 
genes regulated in D2 (B).  K-means clustering clearly distinguished expression patterns 
characteristic of glutamate (upper yellow panels in both A and B) and GABA (lower 
yellow panels in both A and B) neurons. Green and red panels show time course data 
from the present study (C=control, E=ethanol at different time points).  The expression 
values of alcohol-sensitive genes were normalized to show an up- (green) or down- (red) 
regulation compared to control.  Fold change refers to the difference between lowest 
(black) and highest (bright yellow) expressing neurons. 
Figure 4.4:  Cellular classification of differentially expressed genes. 
 
 
 135
 136
 The expression patterns of the genes enriched in the glutamate and GABA 
neuronal populations represented all 10 PLS patterns, to varying degrees (Figure 4.5).  A 
difference in the distribution of PLS patterns existed between the glutamate and GABA 
neuronal populations (χ2(9) = 17.2; p < 0.05).  This difference was manifested in at least 
two different ways, as seen in Figure 4.5:  (1) A large difference in the number of genes 
expressed in excitatory versus inhibitory neurons was evident for genes with expression 
patterns matching PLS patterns 1, 2, 3 and 9 and (2) PLS patterns of intoxication and 
early withdrawal (1-4) have a greater percentage of genes expressed in inhibitory neurons 
while patterns of late withdrawal and neuroadaptation (5-10) have a greater percentage 
expressed in excitatory neurons.  Our findings suggest that excitatory and inhibitory 
neurons in the PFC require different mechanisms for molecular and cellular adaptation to 
alcohol and that the cellular temporal adaptation to the presence of alcohol is cell-type 
specific. 
Figure 4.5:  Frequency distribution of PLS patterns (x axis) of genes shown in 
Figure 4.4.  Genes enriched in either glutamate (ALL_Glut) or GABA (ALL_GABA) 
neuronal populations are shown according to their PLS patterns from Table A.2 (data 
collapsed across strains). A comparison of the PLS pattern distribution between 
glutamate and GABA populations revealed differences (χ2(9) = 17.2; p < 0.05). 
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Conclusions 
Physiological and behavioral responses to alcohol in both humans and mice are 
complex.  A central hypothesis of alcohol dependence focuses on the idea that as the 
brain adapts to the presence of alcohol (during a binge episode or over the course of 
chronic exposure), changes in signal transduction, synaptic activity and gene transcription 
elicit downstream effects that rewire the molecular and anatomical neurocircuitry of the 
brain.  Eventually, neuroadaptation to the alcohol alters brain physiology to the point that 
normal brain function becomes physically impossible in the absence of alcohol.  Using 
microarray analysis of a common mouse model of acute alcohol dependence, we show 
that a large dose of alcohol results in a complex molecular response detected as a 
temporal pattern of transcriptome remodeling in the PFC.  The analysis detected over 700 
differentially expressed genes that showed genetically divergent alcohol responsiveness 
in PFC across the stages of intoxication, withdrawal, recovery and neuroadaptation.  In 
addition, 84 genes showed strain-independent expression changes throughout the 24 hour 
time course.  The candidate genes fit 10 unique PLS temporal patterns giving, for the first 
time, specific information about alcohol-mediated transcriptional neuroadaptation on a 
genomic scale.   
As expected, genetic, non-alcohol responsive differences in brain (PFC) gene 
expression between the two strains were detected, consistent with previous 
comprehensive studies using the B6, D2 mouse model (Chesler et al., 2003; Kerns et al., 
2005).  Gene expression studies using alcohol-naïve animals are an important 
contribution to the growing list of candidate genes for alcohol-related traits.  A list of 
3800 candidate genes for predisposition to alcohol consumption was achieved using nine 
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naïve mouse models that diverge in alcohol preference, demonstrating the use of naïve 
strains to identify potential predisposition genes for alcohol-related traits (Mulligan et al., 
2006).  
In silico promoter and functional analyses demonstrated that the genetic 
divergence in the molecular consequences of an acute dose of alcohol extend beyond the 
level of gene transcription.  Genotype- and direction-dependent transcriptional control 
was evident during intoxication, as shown by the presence of unique TFBSs upstream of 
the genes with increased and decreased expression in the two strains.  As well, very little 
overlap existed between overrepresented functional categories in the B6 and D2 mice, 
with a trend towards signaling in B6 and metabolism in D2, suggesting that the strains 
diverge in their alcohol-related compensatory mechanisms in the PFC.  Several functional 
categories identified in the current study were similar to those identified in previous 
studies using rodent models of alcohol dependence; including metabolism, signal 
transduction, development and transcription/translation (Daniels and Buck, 2002; Saito et 
al., 2002; Treadwell and Singh, 2004; Kerns et al., 2005).  Of note is the MAPK pathway; 
identified in this study as overrepresented during intoxication and withdrawal in the B6 
mouse and previously implicated in hippocampal gene expression changes following 
chronic alcohol exposure in B6 mice (Daniels and Buck, 2002) as well as overrepresented 
in several lines and strains of naïve alcohol-preferring mice (Mulligan et al., 2006).  
Further in silico analysis provided likely cellular identities within the PFC for genes that 
are expressed as a result of acute alcohol exposure, giving insight into the next level of 
specificity—beyond a single brain region, and providing another step towards 
understanding the underlying mechanisms of alcohol dependence. 
In summary, microarray analysis of the PFC transcriptome in B6 and D2 mice 
revealed a striking genotype- and time-dependent remodeling by alcohol intoxication and 
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its subsequent physiological consequences.  Nearly 1000 differentially expressed genes 
were narrowed by functional analysis to highlight potential candidate genes for further 
study.  It is important to recognize; however, that these are candidate genes only and that 
their expression at specific time points does not necessarily indicate that they play a 
direct role in mediating the corresponding temporal physiological response(s) to alcohol.  
Further studies are warranted to test whether the transcriptional responses are a direct 
effect of intoxication or withdrawal, for example, or whether they are downstream effects 
of signal transduction or biochemical pathways affected at a previous time point.  In 
addition, the current bioinformatics tools for functional characterization of genes are 
incomplete; therefore, results obtained from them can only provide partial insight into the 
potentially important functional groups and TFBS usage related to acute alcohol 
dependence.   
The PFC is an important brain region in mediating the rewarding effects of 
alcohol and is a region susceptible to damage in chronic alcoholics.  We have shown that 
the PFC undergoes a complex transcriptome remodeling in response to alcohol. New 
hypotheses about the role the genes identified in our study may play in mediating alcohol 
consequences, such as tolerance and dependence, can now be tested. 
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CHAPTER 5:  DISCUSSION 
Summary 
Alcohol dependence is a complex polygenic disease influenced by both 
environmental factors and genetic makeup.  Mouse models of alcohol-related traits are 
commonly used to identify the genetic factors that contribute to specific physiological 
and behavioral consequences of alcohol exposure.  The B6 and D2 inbred strains of mice, 
which diverge in several alcohol-related traits, were used in two complementary gene 
expression studies to identify potential candidate genes for alcohol dependence.  The 
mice were given a single, high dose of alcohol and brain gene expression changes were 
monitored over a time course using mRNA Differential Display (DD) and cDNA 
microarray analysis.  The DD study was performed first in order to generate additional 
clones for the cDNA microarrays.  150 new unique brain targets were added to the cDNA 
clone sets as a result of the DD screen.  Over 700 genetically divergent, alcohol-sensitive 
gene expression differences between the prefrontal cortices (PFC) of the B6 and D2 mice 
were identified in the cDNA microarray analysis.  A combination of statistical tests (t-
test, F-test and PLS analysis) and K-means cluster analysis revealed striking strain-
specific temporal patterns of gene expression induced by alcohol.  In addition, genotype-
independent changes in gene expression were identified as a result of intoxication in both 
strains, as well as baseline genetic differences between the PFCs of B6 and D2.  In silico 
analysis of the genotype-dependent differentially expressed genes demonstrated 
genetically divergent trends in function, transcription factor binding site (TFBS) usage 
and cell-type classification.  The results indicate that the brains of B6 and D2 mice have 
very different cellular and molecular responses to acute alcohol exposure. 
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mRNA Differential Display as a complement to cDNA microarray 
analysis 
One of the major advantages to cDNA microarray analysis over more traditional 
gene expression detection techniques is that tens of thousands of genes can be screened at 
once for changes in expression.  However one of the drawbacks to using microarrays is 
that the results are dependent on the clones printed on the array.  A less biased method of 
gene expression detection is mRNA Differential Display (DD).  In DD, primer pairs are 
used to amplify every (theoretically) expressed gene at any given time in an organism.  
Therefore, DD was used as a complementary technique to the microarrays in order to 
increase the number of brain-specific, genetic and/or alcohol-sensitive genes on the 
arrays.  About 150 DD clones were combined with the existing microarray clones to 
become additional targets on the arrays. 
Our experimental design of combining DD and cDNA microarrays to increase the 
number of brain-specific, genetic and/or alcohol-sensitive genes did not prove to be as 
beneficial as we had anticipated for several reasons.  First, DD is labor and time 
intensive.  Each sample (mouse brain for example) must be PCR amplified 240 times and 
each of those reactions must be run on a sequencing gel to identify differentially 
expressed genes.  The gels must be examined, the bands excised, subcloned and 
sequenced, and the sequencing results must be queried using a database of known genes 
and ESTs.  Depending on the size of the experiment, this process can take several months 
to complete.  Second, although 150 new clones were added to the arrays as a direct result 
of the DD screen, only about 10% of the named genes were novel to the array clone sets.  
Third, the purpose of the DD screen was to generate novel targets that would contribute 
to and enhance the microarray results by increasing the number of brain-specific, genetic 
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and/or alcohol-sensitive genes on the arrays, yet very few of the DD clones were 
differentially expressed in the microarray experiment.  For example, of the ~30 genes that 
were differentially expressed between the whole brains of the saline-treated (control) B6 
and D2 mice in the DD experiment, only three were found to be differentially expressed 
in the microarray experiment (t-test p-value of 0.001 between B6 and D2 saline treated 
animals).  Furthermore, none of the 700 genetically divergent, alcohol-sensitive genes 
identified in the microarray experiment were DD clones.  The following paragraph 
provides several possible explanations for the disparity between the two experiments. 
One of the major differences between the DD and microarray studies was the 
tissue type used in each.  Whole brain was examined in the DD study while PFC was 
examined in the array study.  It is likely that only a small fraction of the differentially 
expressed genes from the DD study were expressed in the PFC, given that it is such a 
small brain region.  Therefore, it may be invalid to assume that the majority of the DD 
clones would be detected in the array experiment.  Brain gene expression was examined 
at two time points (2 hours and 6 hours) following alcohol administration in the DD 
experiment while in the array experiment, four time points of 2, 7, 12 and 24 hours were 
studied.  The 700 genes identified as differentially expressed in the array experiment 
included genes that increased or decreased in expression at 12 hours and/or 24 hours 
only.  Since these two time points were not included in the DD experiment, the total 
number of differentially expressed genes across time is not directly comparable between 
the two studies.  Finally, methodologically speaking, DD is a more sensitive technique 
than arrays in terms of detecting small quantities of RNA while it is a less sensitive 
technique in terms of the criteria required to deem a gene differentially expressed.  To 
elaborate, as PCR amplification is the basis of DD, a very small amount of RNA can be 
present in the cell and it will still be detected on the sequencing gel using radioactivity.  
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On the other hand, for microarrays, an equivalent small amount of RNA (cDNA) must 
find its complement on a microscope slide containing tens of thousands of other cDNA 
species, bind well to that complementary strand, emit enough fluorescence to be detected 
by the scanners and be given a high enough intensity value (during the scanning process) 
such that it is interpretable by the array software.  In the DD experiment, an n of 2 was 
sufficient to determine whether a gene was differentially expressed or not.  If, in those 
two samples, the amount of radioactivity was different between saline treated animals 
and alcohol treated animals, for example, then the gene passed the criteria for differential 
expression.  However, in the array experiment, that same gene must have been present 
(good spot morphology and high enough intensity value) on 6 out of 7 n arrays for both 
the saline and alcohol treated samples, had low enough variance to pass strict p-value 
cutoffs when compared to each other and had to have been appointed a pattern of 
expression through PLS analysis that matched one of ten pre-determined biologically 
relevant temporal expression patterns. 
 
A comparison of studies 
One of the goals of the study was to identify PFC-specific temporal patterns of 
alcohol-related gene expression in a standard mouse model of acute dependence (Buck et 
al., 1997) using cDNA microarrays.  PLS analysis coupled with statistical tests for 
significance (t-test and F-test) were used to fit 10 biologically relevant patterns of 
expression encompassing the first 24 hours after alcohol exposure.  About 825 genes 
were differentially expressed in one or both of the strains (B6 and D2) over the 24 hour 
time course, which included a 2, 7, 12 and 24 hour time point following alcohol 
exposure. 
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Several previous studies have examined the effects of alcohol exposure on the 
rodent brain transcriptome (Daniels and Buck, 2002; Rimondini et al., 2002; Saito et al., 
2004; Treadwell and Singh, 2004; Kerns et al., 2005; Rulten et al., 2006).  Consistent 
with our findings, about 1-3% of the genes surveyed (i.e., genes present on the 
microarray) in these studies were differentially expressed as a result of alcohol exposure.  
However, a comparison of the differentially expressed genes from the present study with 
those found in three previous studies (Daniels and Buck, 2002; Rimondini et al., 2002; 
Kerns et al., 2005) revealed very few overlapping genes.  The three studies selected for 
comparison are similar to the present study in genotype (Daniels and Buck, 2002; Kerns 
et al., 2005), dose of alcohol (Daniels and Buck, 2002), time point after alcohol exposure 
(Daniels and Buck, 2002) or brain region (Rimondini et al., 2002; Kerns et al., 2005).  A 
total of 36 genes were common to at least two of the four studies. 
There are a number of possible reasons why so few overlapping genes were 
found.  The first is that the arrays were done in different laboratories, using different 
array platforms (cDNA and oligonucleotide) with different criteria for determination of 
gene expression “significance.”  Several studies have examined the agreement of 
microarray results across lab and across platform and found the following:  1) The 
agreement among platforms (short oligo, long oligo, cDNA) was greater within the same 
lab than it was between labs (Bammler et al., 2005; Wang et al., 2005), 2) cDNA arrays 
showed poor concordance with Affymetrix and spotted oligonucleotide arrays (Woo et 
al., 2004) and 3) Short oligo, long oligo and cDNA arrays produced similar results only if 
the criterion for differential gene expression was the direction, not the magnitude, of 
change (Petersen et al., 2005).  In addition, in the Petersen et al. study, 6430 genes were 
common among the three platforms…a condition that was not true for the four alcohol-
related studies compared here.  Therefore, the second reason why such disagreement 
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exists among the four studies being compared is the difference in gene composition of the 
arrays.  Thirdly, the entity used to compare array results was the gene symbol.  
Importantly, not all genes have gene symbols and some genes can be represented by more 
than one symbol.  In addition, with time, more unknown genes were assigned symbols 
and the studies compared here were done several years apart. 
Biological reasons exist as well to explain the discrepancy in array results.  
Although commonalities exist among the compared studies, no single study mimics the 
genotype, dose of alcohol, brain region and time points surveyed post-alcohol exposure 
of the present study.  One of the biggest differences that sets the current study apart from 
all previous ones is the utilization of a time course to examine gene expression changes 
after alcohol exposure.  All of the genes deemed significantly differentially expressed in 
the present study had to match one of 10 predetermined temporal expression profiles.  In 
all previous studies, genes labeled as differentially expressed by alcohol had to be altered 
at a single time point only.  Such a difference in criteria for differential expression could 
create very different results. 
 
Computational tools as a means to further characterize differentially 
expressed genes 
The present study demonstrated that a single, high injection of alcohol in B6 and 
D2 mice results in a striking strain-specific pattern of transcriptome remodeling in the 
prefrontal cortex.  It has been hypothesized that genes with similar (alcohol-related) 
temporal expression patterns may be co-regulated by common transcription factors 
(Altman and Raychaudhuri, 2001; Schulze and Downward, 2001).  This hypothesis was 
tested by searching for overrepresented transcription factor binding sites (TFBS) in the 
upstream region of genes expressed in B6 or D2 during intoxication.  oPOSSUM analysis 
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uncovered genotype-dependent and -independent TFBS usage for intoxication-related 
increases and decreases in gene expression in the PFC, suggesting that some transcription 
factors were specifically regulating gene expression in only one of the genotypes in 
response to the alcohol exposure while other transcription factors were regulating gene 
expression based on alcohol exposure alone.  Considering the minimal overlap in genes 
expressed during intoxication between B6 and D2 (and therefore in the gene lists 
uploaded to the oPOSSUM program), the existence of strain-specific transcriptional 
regulation is not surprising.  However, common overrepresented TFBSs were found in 
genes up-regulated by alcohol in both B6 and D2, suggesting that even though very few 
(if any) actual genes were common in the lists of up-regulated genes in B6 and D2 during 
intoxication, the transcription factors that regulate the expression of those up-regulated 
genes may be the same.  The disparity between the strain-specificity of the up-regulated 
genes and the non-strain-specificity of the overrepresented TFBSs suggests that some 
transcription factors are activated in response to alcohol, but then activate different 
individual genes.  Of note is that several of the genotype-independent TFBSs are 
sequence motifs for common transcription factors.  NF-kappaB activates gene expression 
in response to inflammation while CREB activates neuronal gene expression in response 
to growth factors, hormones and neurotransmitters.  With such general requirements for 
transcriptional activation, it is plausible if not highly likely that alcohol could activate 
these two transcription factors as a general response mechanism to alcohol, in a 
genotype-independent manner. 
Although TFBS analysis of the intoxication-related genes from the present study 
has given insight into the potential complement of transcription factors that may be 
regulating those genes, the methodology is still in its infancy and therefore the results 
should be interpreted accordingly.  For example, in the present study, only about 30% of 
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the significant genes uploaded into the oPOSSUM program were recognized and used in 
the overrepresentation analysis.  In addition, when a less stringent set of criteria were 
used in a different promoter analysis program (MATCH) to search for TFBSs, most of 
the genes contained hundreds if not thousands of potential TFBSs, indicating that setting 
limitations on programs to ensure the output is of manageable size and interpretation, 
some information might be lost.   
The use of in silico analyses to extend or support microarray data is becoming 
more common (Mulligan et al., 2006; Ponomarev et al., 2006).  However, the databases 
currently available for promoter analysis (Vadigepalli et al., 2003; Ho Sui et al., 2005) 
and functional annotation of genes are incomplete.  For example, when querying the GO, 
KEGG and Biocarta databases within WebGestalt to functionally annotate the significant 
genes from this study, only 85% of the genes had gene symbols assigned to them.  Of the 
genes with symbols, only 85% of them were recognized by the WebGestalt program.  
Taken together, only 72% of the significant genes were used to assign overrepresented 
functional categories to the entire list.  In addition, the fact that a gene has a gene symbol 
assigned to it does not guarantee that its function is known, adding another layer of 
uncertainty to the final functionally annotated gene list.  Therefore, caution should be 
exercised when drawing conclusions about the nature of the functional annotations 
assigned to lists of significant genes.  Although they can provide insight into the 
functional trends among significant genes, they cannot provide solid conclusions. 
 
Narrowing the focus:  from whole brain to brain region 
The brain is an incredibly heterogeneous and complex tissue.  Billions of neurons 
and glial cells, encompassing a wide range of cell types makes gene expression studies of 
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the brain particularly challenging (Nisenbaum, 2002).  It is not uncommon for genes of 
functional significance to be expressed at low levels and in very specific subpopulations 
of cells (Nisenbaum, 2002; Mirnics and Pevsner, 2004).  As a result, significant changes 
in gene expression may be difficult to detect in whole brain.  By focusing on a single 
brain region, small but significant changes in gene expression may be more easily 
detectable due to the fact that they are not being masked by an abundance of cell types 
and/or more highly expressed transcripts (Mirnics and Pevsner, 2004). 
A second advantage to focusing brain gene expression studies on a particular 
region is that individual brain regions often differ in their anatomical, physical, cellular, 
electrophysiological and functional characteristics.  Assessing the transcriptional profiles 
of single brain regions offers the potential to link the gene expression changes to one or 
more of these characteristics (Letwin et al., 2006).  For example, it has been established 
that the prefrontal cortex is selectively damaged by long term alcohol exposure (Kril et 
al., 1997; Kril and Halliday, 1999; Obernier et al., 2002a; Obernier et al., 2002b).  
Monitoring the transcriptional changes over time as the physical damage is occurring 
may give insight into the mechanisms underlying the damage. 
The results of the present study demonstrate that a strong transcriptional response 
to alcohol exists in the prefrontal cortices of B6 and D2 mice.  Furthermore, the genes 
identified as differentially expressed in the whole brains of these mice using DD differ 
from the genes identified as differentially expressed in the PFCs using microarrays.  In 
addition, a separate experiment performed in the Bergeson lab that was designed to test 
the effects of chronic alcohol exposure on D2 mice in a brain-region dependent manner 
found very little overlap among the genes expressed in the six brain regions tested 
(olfactory bulb, striatum, hippocampus, cortex, cerebellum and midbrain) (Bergeson, lab, 
unpublished data), indicating that each region had its own unique expression profile in 
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response to chronic alcohol exposure.  The results of the acute and chronic studies 
suggest that more insight may be gained into the molecular mechanisms underlying a 
disease such as alcohol dependence by studying the expression profiles of individual 
brain regions as opposed to the whole brain. 
 
Limitations of study 
As discussed previously, no single animal model can completely recapitulate all 
the symptoms of alcohol dependence.  Inbred strains and selected lines of mice have been 
successfully used to model specific clinically relevant traits.  For example, a single 
injection of a large dose of alcohol (4 g/kg) has been shown to cause withdrawal (a sign 
of physical dependence) in D2, and to a lesser extent, B6 mice (Buck et al., 1997).  The 
present study utilized this model to identify gene expression changes occurring 
concomitantly with intoxication, withdrawal and neuroadaptation over a 24 hour period 
after a 4 g/kg injection of alcohol.  While the acute physical dependence model can be 
used to identify the transcriptional response in brain to such a large dose of alcohol, it 
cannot give insight into the mechanisms underlying the choice to drink the equivalent of 
such a large dose.  Voluntary oral consumption of alcohol in mice rarely produces 
substantial blood ethanol concentrations (BECs), nor do the mice exhibit the loss of 
control often seen in human alcoholics (Finn et al., 2005; Rhodes et al., 2005).  
Therefore, the limitations of this model include the degree of voluntary consumption that 
is present in human alcoholics.  Although progress has been made in creating drinking 
paradigms (Finn et al., 2005; Rhodes et al., 2005) and new mouse models (Blednov et al., 
2005) to increase voluntary alcohol consumption, no drinking model yet exists that can 
mimic the physiological effects of a single 4 g/kg dose. 
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The gene expression changes occurring across time in this study parallel 
important molecular and physiological changes that result from acute alcohol exposure, 
including intoxication and withdrawal.  It is important to realize, however, that the genes 
identified in this study are only candidate genes, and that further experiments are 
necessary to determine whether the genes directly contribute to intoxication, withdrawal 
or neuroadaptation after a single, high dose of alcohol.  To date, no connection has been 
made between prefrontal cortex function and acute alcohol withdrawal. Therefore, the 
gene expression changes occurring at each time point in the time course (2, 7, 12 and 24 
hours) following alcohol exposure may or may not be directly related to the concurrent 
alcohol response.  It is possible that the results of this study revealed a previously 
unknown connection between the prefrontal cortex and acute alcohol dependence; 
however, that hypothesis would have to be specifically tested.  What can be concluded is 
that acute alcohol exposure induces a strong transcriptional response in the PFC that is 
strain-specific and time-dependent. 
 
Future directions 
Microarray analysis has the potential to provide hundreds if not thousands of 
genes for further study.  In our study, differentially expressed genes were narrowed by 
classification into functional categories, by TFBS usage and by cellular profiles.  Several 
other types of bioinformatics tools are also available, including programs that assign 
genes to pathways (PathwayArchitect™) and online tools such as mouse brain atlases 
that allow the user to search for specific genes among hundreds of digital in situ 
hybridization images (http://www.brainatlas.org/ and (Carson et al., 2005)).  These tools 
provide a mechanism by which to build gene networks, highlight biochemical pathways 
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and map cellular locations of genes—all of which help to give a more three-dimensional 
view of gene expression changes and possibly better insight into the molecular 
consequences of alcohol exposure. 
Previous studies have demonstrated a clear difference in gene expression profiles 
among several brain regions at the basal level (Letwin et al., 2006) and as a result of 
chronic alcohol exposure (Bergeson lab, unpublished data).  It is likely that acute alcohol 
exposure also causes a unique, brain region-specific transcriptional response as well.  Six 
other brain regions—olfactory bulb, posterior cortex, striatum, hippocampus, midbrain 
and cerebellum—were dissected along with the prefrontal cortex after a single, high 
injection of alcohol in the B6 and D2 mice.  Microarray analyses are currently underway 
to identify the alcohol-induced temporal expression patterns in these regions.  Once 
completed, a comparative analysis could be done to identify brain-region specific gene 
expression patterns following acute alcohol exposure. 
 
Conclusions 
The results of this study demonstrated that a single, high dose of alcohol was 
capable of causing considerable transcriptome remodeling in the prefrontal cortices of B6 
and D2 mice.  Furthermore, over 700 transcriptional changes identified were genotype- 
and time-dependent, demonstrating the dichotomy in acute alcohol-induced brain gene 
expression between the B6 and D2 strains. 
This study was the first to monitor gene expression over a time course following 
acute alcohol exposure in mice.  Transcriptional responses to alcohol, regardless of dose 
or the mode of exposure, encompass a range of time points, from initial exposure and 
intoxication to the time the alcohol clears the system to the short and long-term 
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consequences that follow.  By focusing solely on gene expression changes during 
intoxication or withdrawal, as previous studies have, other important events that may 
explain the transition from intoxication to withdrawal or from withdrawal to 
neuroadaptation may be missed.  By identifying gene expression changes as a function of 
time, a better understanding of the progression of events that may ultimately protect B6 
from severe physical dependence while allowing D2 to be susceptible to it may be 
achieved. 
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Appendix 
Table A.1:  Differential display clones printed on the cDNA microarrays.  The clones 
isolated from the DD screen that were added as targets to the microarrays are listed.  
About 150 unique known genes, ESTs and unknown sequences were isolated.  The 
column labeled “regulation” lists the expression profile of each clone (G = genetically 
divergent expression between B6 and D2 control mice, E = ethanol-sensitive, non-
genetically divergent expression and G/E = genetically divergent, ethanol-sensitive 
expression).  The column labeled “oligo” lists the number (1-80) of the forward primer 
and the letter (A,G,C) of the anchor on the reverse primer.  EST = expressed sequence 
tag.  E/S = E score from BLAST results. 
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Table A.2:  Alcohol-related strain differences in gene expression.  The alcohol-related 
differentially expressed genes in B6 and D2 are listed.  The gene order corresponds to the 
gene order in Figures 4.1A (B6) and 4.1B (D2).  The B6 genes are listed first and the D2 
genes are listed second.  Note that the genes names are current as of July 31, 2006.  
  164
  165
  166
  167
  168
  169
  170
  171
  172
  173
  174
  175
  176
  177
  178
  179
  180
  181
  182
  183
  184
  185
  186
  187
  188
 189
 
Table A.3:  Intoxication-related differentially expressed genes in B6 and D2 mice.  
The genes in this list correspond to Figure 4.2.  Note that the genes names are current as 
of July 31, 2006. 
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Table A.4:  Differentially expressed genes between B6 and D2 control mice.  The 
genes in this list correspond to Figure 4.3.  Note that the genes names are current as of 
July 31, 2006. 
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